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ABSTRACT 
Elevated expression of proteins, such as those involved in native antibiotic resistance 
pathways or introduced to enable biosynthesis of a metabolic engineering target, frequently 
leads to increased fitness cost. This can result in reduced growth and places selective 
pressure on cells. In conditions where there is diversity in expression within the population, 
this can result in cells with higher fitness out-competing their low-fitness counterparts. In 
the antibiotic resistance context, differential fitness costs caused by antibiotic resistance 
machinery can be exploited to select against resistant bacteria. However, in biotechnology 
applications, introducing burdensome synthetic constructs often requires additional 
engineering to increase genetic stability and maintain production.  
 
In this thesis, we investigate the origin of fitness costs and strategies for either exploiting 
or reducing it, focusing on specific examples related to antibiotic resistance and metabolic 
engineering. In the resistance work, we study the multiple antibiotic resistance activator 
	
	 vii 
MarA and related proteins in Escherichia coli. We quantify the differential fitness cost 
impacts of salicylate on E. coli antibiotic resistance variants. We demonstrate that 
salicylate, the natural inducer of MarA, imposes a higher fitness cost on resistant cells 
compared to the susceptible counterparts, making it possible to bias bacterial population 
membership towards those cells that are susceptible. In a second study, we focus on the 
role of salicylate in antibiotic tolerant persister cell formation, finding that salicylate 
induces reactive oxygen species and consequently persistence. In the metabolic 
engineering parts of the thesis we first review the mechanisms of fitness cost and existing 
strategies to ameliorate cost and cell-to-cell variation. Next, we present a technique for 
reducing fitness cost while maintaining production that takes advantage of transcription 
factor decoy sites to regulate biosynthesis in E. coli. Using arginine production as a model 
system, the transcription factor decoy is able to increase production by 16-fold without 
detectable growth differences.  
 
Together, the thesis provides an understanding of the origins and mechanisms of fitness 
cost in the context of antibiotic resistance and metabolic engineering. It also introduces 
strategies to exploit fitness costs to select against resistant bacteria and engineering 
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CHAPTER 1: INTRODUCTION 
Overexpression of heterologous proteins, such as those involved in synthetic biology 
constructs or metabolic engineering pathways (Shachrai et al., 2010; Segall‐Shapiro et 
al., 2014; Gyorgy et al., 2015; Borkowski et al., 2016; Ceroni et al., 2018; Darlington et 
al., 2018), in addition to native functional machineries, like those involved in antibiotic 
resistance, frequently lead to elevated fitness costs in bacteria, resulting in lower growth 
and biased population dynamics. The fitness cost associated with these proteins allows an 
opportunity to change population dynamics by exploiting the differences in fitness 
associated with each member in a mixed population containing low and high fitness cells, 
such as antibiotic resistant bacteria being outcompeted by susceptible bacteria in the 
absence of antibiotic (Andersson and Hughes, 2010; Palmer, Angelino and Kishony, 2010; 
Creamer et al., 2017; Hernando-Amado et al., 2017). Moreover, fitness costs also impose 
challenges when we try to produce heterologous proteins in a cell, making these differences 
relevant to biotechnology applications as well (Borkowski et al., 2016). Various strategies 
have been developed to mitigate the cost brought by introduction of heterologous 
constructs aimed at improving genetic stability or increased yields of target products 
(Cookson et al., 2011; Dahl et al., 2013; Segall‐Shapiro et al., 2014; Xu et al., 2014; 
Venturelli et al., 2017; Ceroni et al., 2018; Darlington et al., 2018; Siu et al., 2018; Liao 
et al., 2019). In this thesis, we will discuss fitness cost in the context of two diverse 
applications—antibiotic resistance machinery and metabolic engineering—and strategies 
to exploit or mitigate these costs. These include using the cost of antibiotic resistance 
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machinery to out-compete resistant cells, and to mitigate cost in metabolic engineering to 
increase yields and growth. 
 
1.1 Fitness costs in antibiotic resistance 
Antibiotic resistance is frequently associated with a fitness cost that results from expression 
of burdensome resistance machinery or the acquisition of mutations in conserved genes 
that antibiotics target (Marcusson, Frimodt-Møller and Hughes, 2009; Andersson and 
Hughes, 2010; Wood and Cluzel, 2012; Turner and Dunlop, 2015; Hernando-Amado et al., 
2017). Due to the competitive disadvantage of resistant bacteria in the absence of 
antibiotics, susceptible bacteria may out-compete resistant bacteria in an environment 
without antibiotics, reducing the proportion of resistant cells and rendering the overall 
population susceptible (Levin et al., 1997; Levin, 2002; De Gelder et al., 2004) (Fig. 1-1). 
However, compensatory mutations and precise feedback control of burdensome protein 
expression largely ameliorate the resistant burden (Björkman et al., 2000; Morosini et al., 







Figure 1-1. Schematic diagram of antibiotic resistant cells being out-competed in a mixed 
population of resistant and susceptible cells after antibiotic is removed from the environment. 
 
1.1.1 Mechanisms of fitness cost in antibiotic resistance 
Antibiotics frequently target conserved cellular processes, and to evade antibiotic attack, 
bacteria can acquire mutations in genes related to antibiotic targets. Therefore, it is not 
surprising that mutations in these genes come with a fitness cost. For example, rifampicin 
resistant bacteria have been found to have a fitness burden due to mutations in the RNA 
polymerase subunit-β (RpoB) (Enne et al., 2004). Fusidic acid resistant S. aureous acquires 
mutations in rplF, the 30S ribosomal protein, resulting in small colonies and extremely 
slow growth (Norström, Lannergård and Hughes, 2007). P. aeruginosa acquire mutations 
in nfxB, which leads to fluoroquinolones resistance but impaired motility (Sanchez, 2002).
 
In the case of resistance acquired from horizontal gene transfer, fitness burden may directly 
result from the transfer process (Koraimann and Wagner, 2014), the metabolic cost of 
replication, transcription and translation of foreign genes (Bragg and Wagner, 2009; 
Shachrai et al., 2010), or indirectly from integration of foreign DNA into the genome 
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(Canchaya, Fournous and Brüssow, 2004) or cyto-toxicity of foreign proteins (Geiler-
Samerotte et al., 2011).
 
Bacteria can also survive antibiotic attack through persister formation (Kussell et al., 
2005). Persisters are cells that enter a dormant state stochastically or by induction from an 
environmental stressor (Lewis, 2010). Persister cells exhibit reduced growth and metabolic 
activity (Shah et al., 2006), resulting in a high tolerance toward antibiotics, since most 
antibiotics target rapidly growing cells. Although only a small fraction of the persister sub-
population completely stops growth, lengthened lag phases and reduced survival during 
stationary phase contribute to the fitness cost associated with persister formation. These 
significant costs explain why only a small proportion (<1%) of cells are persisters 
(Stepanyan et al., 2015).
 
1.1.2 Exploiting resistance cost to reverse antibiotic resistance 
Since antibiotic resistance frequently comes at a cost, a possibility that might alleviate the 
spread of resistance or even reverse trends would be to out-compete the resistant, but 
burdened bacteria with their high-fitness susceptible counterparts in an antibiotic-free 
environment. Indeed, studies have shown that bacteria that carry burdensome resistance 
machinery can be out-competed by susceptible strains in a competitive setting (Levin et 
al., 1997; Levin, 2002; De Gelder et al., 2004). However, the fitness disadvantage of 
resistant bacteria is typically either modest or quickly alleviated due to compensatory 
mutations or precise regulations of the taxing resistance genes (Björkman et al., 2000; 
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Dahlberg and Chao, 2003; De Gelder et al., 2004).  For example, tight control of the 
tetracycline resistance gene tetA by the transcription factor TetR minimizes the fitness cost 
of tetracycline resistance. The process of out-competing resistant bacteria by their 
susceptible counterparts is very slow: a computational study has shown that it would take 
1.5 years to out-compete 99% of tetracycline resistant cells in the absence of antibiotic (De 
Gelder et al., 2004). Similar tight regulation is widely found in other antibiotic resistance 
genes, such as the multiple antibiotic resistance activator marA by its repressor MarR 
(Cohen, Hachler and Levy, 1993) and the multidrug efflux pump acrAB by AcrR (Ma et 
al., 1996).
 
1.1.3 Interaction with environmental inducers can reshape resistance fitness burden 
Environmental chemicals can turn on the tight regulation of antibiotic machinery and 
impose a significant burden on resistant bacteria (Palmer, Angelino and Kishony, 2010; 
Wood and Cluzel, 2012; Creamer et al., 2017). Therefore, even bacteria with tight 
regulated antibiotic resistance machinery can be effectively out-competed if specific 
environmental chemicals co-exist. For example, anhydrotetracycline, the major decay 
product of the antibiotic tetracycline, can select against tetracycline resistant cells (Palmer, 
Angelino and Kishony, 2010). As tetracycline is widely used clinically and agriculturally, 
anhydrotetracycline is found in soil and wastewater (Sarmah, Meyer and Boxall, 2006; Jia 
et al., 2009), and plays an important role in the interplay between tetracycline resistant and 
susceptible cells. Although the fitness burden is negligible in tetracycline resistant bacteria 
due to the precise regulation by TetR (‘Effects of carriage and expression of the Tn10 
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tetracycline-resistance operon on the fitness of Escherichia coli K12.’, 1989; Björkman et 
al., 2000), cellular burden can be significantly increased when repression by TetR is 
released by anhydrotetracycline, biasing the bacterial population away from tetracycline 
resistant cells. Chemicals used in the food and cosmetic industries have also been found to 
elevate the burden in resistant bacteria (Wood and Cluzel, 2012; Creamer et al., 2017). A 
recent study found that E. coli can lower antibiotic resistance levels by obtaining mutations 
in the antibiotic resistance genes marA and rob in environments with the food preservative 
benzoate (Creamer et al., 2017), suggesting that resistant cells have lower fitness compared 
with susceptible cells in benzoate-containing conditions.
 
1.1.4 Multiple antibiotic resistance activator (marA) and its inducer salicylate as model 
systems to study fitness cost 
Salicylate, the major metabolite of aspirin and a canonical inducer of the multiple antibiotic 
resistance activator (MarA) (Cohen et al., 1993; Martin and Rosner, 1995), has also been 
shown to alter bacterial physiology by reducing cell growth and inhibiting ATP synthase 
expression (Pomposiello, Bennik and Demple, 2001; Wood and Cluzel, 2012). Salicylate 
induces expression of the multiple antibiotic resistance activator (marA) by de-repressing 
its repressor MarR, resulting in regulation of more than 40 antibiotic resistance related 
genes (Cohen et al., 1993; Martin and Rosner, 1995). This, in turn, causes elevated 
antibiotic resistance levels and reduced cell growth. Susceptible mutants of E. coli with 
modifications in marA also show higher fitness in environments with salicylate (Creamer 
et al., 2017). These studies suggest that salicylate can bias E. coli communities towards 
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antibiotic susceptible populations, as it can induce expression of antibiotic resistance 
machinery and therefore increase resistance cost. 
1.2 Fitness costs in metabolic engineering 
Expression of foreign DNA can be costly, especially when cellular resources are redirected 
from endogenous processes (Borkowski et al., 2016). Thus, synthetic biologists have 
developed tools and strategies to alleviate the fitness cost associated with metabolic 
engineering (Wang and Dunlop, 2019). Goals of these efforts include increased genetic 
stability of synthetic constructs and enhanced product yields.
 
1.2.1 Origin of fitness costs and strategies to alleviate them in metabolic engineering 
Cellular resources can be redirected to support the processes that are involved in the 
expression of the newly introduced genes. Since cells only possess a finite pool of 
resources, such as replication, transcription and translation machinery, the additional 
demands of resources for the expression of genes involved in metabolically engineered 
pathways can impose a fitness burden to the cell, which can lead to slower growth, reduced 
genetic stability and lower production (Scott et al., 2010; Shachrai et al., 2010; Geiler-
Samerotte et al., 2011; Ceroni et al., 2015; Gyorgy et al., 2015; Borkowski et al., 2016; 
He, Murabito and Westerhoff, 2016; Liao et al., 2019) (Fig. 1-2).
 
Previous studies have shown that competition for transcriptional and translational 
resources are the major sources of burden (Sorek et al., 2007; Shachrai et al., 2010; Gyorgy 
et al., 2015). In bacterial contexts, cost appears to mainly arise from the ribosome resources 
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that need to be allocated for the expression of heterologous genes (Sorek et al., 2007; 
Shachrai et al., 2010). RNA polymerases are also a limiting resource that contribute to 
cellular burden (Gyorgy et al., 2015). Other factors that impose burden in metabolic 
engineering include protein degradation machinery (Cookson et al., 2011), tRNAs (Plotkin 
and Kudla, 2011) and amino acids pools limitation (Scott et al., 2010) and product toxicity 
(Turner and Dunlop, 2015).
One way to ameliorate fitness burden is design resource allocation circuits to balance 
between the demands of native and heterologous pathways. For example, a ribosome 
resource allocator has been developed to redirect translational processes to different 
ribosome pools using a synthetic 16S rRNA to allow dynamic allocation of translational 
resources (Darlington et al., 2018). Similar strategies have been employed to develop 
transcriptional resource allocators to steer RNA polymerase resources using orthogonal 
sigma factors (Segall‐Shapiro et al., 2014). A more general strategy that allows cells to 
cope with the general burden of heterologous gene expression is the use of burden 
reporters. Using RNA-seq, Ceroni et al. identified a group of heat-shock responsive 
promoters in E. coli that can serve as global burden reporters when heterologous gene 
expression is detrimental to the cell. Genetic circuits built on these burden reporters allow 
dynamic control to balance heterologous pathway expression based on specific cellular 




Figure 1-2. Schematic diagram shows examples of the origins of fitness costs in metabolic 
engineering. 
1.2.2 Transcription factor decoy for metabolic pathway regulation with low fitness cost 
Apart from competition of resources between heterologous and native functional pathways, 
fitness cost also occurs when native genetic network is disrupted (He, Murabito and 
Westerhoff, 2016), such as knocking out transcription factors to redirect metabolic flux. 
Although complete removal of a transcription factor may enhance production, this may 
have detrimental consequences for the host cell due to its broader regulatory role (He, 
Murabito and Westerhoff, 2016). One way to reduce this fitness burden is to knock-down 
the transcription factor rather than completely remove it. For example, a recent study 
suggests that using the CRISPRi system to knock-down the transcription factor ArgR 
allows for a two-fold higher growth rate compared to the full knock-out, while productivity 
remains similar (Sander et al., 2019). However, the system for knocking down expression 
may also introduce detrimental effects. For example, toxicity to the host cell has been 
reported with the CRISPRi system (Cui et al., 2018), which is commonly used for 
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regulating gene expression; cellular burden is also expected when expressing gRNA and 
dCas9 proteins (Shachrai et al., 2010; Gyorgy et al., 2015). Moreover, many of the genetic 
constructs required for performing knock-downs of gene expression require the 
introduction of multiple plasmids to carry the system, which limits their usage in metabolic 
engineering, where clusters of heterologous genes can require a multi-plasmid system to 
be expressed. An alternative small size system that can partially remove the effect of 
transcription factor without increasing fitness cost to the host could help to further increase 
yields and productivity.
 
Decoy transcription factor binding sites are DNA sequences that can competitively bind 
with transcription factors to reduce free transcription factors, therefore affecting gene 
expression (Brophy and Voigt, 2014). Previous studies have employed decoy binding sites 
to alter response thresholds or lower noise in genetic circuits. Bacterial decoy binding sites 
are generally short, typically containing a ~30bp DNA sequence, and do not require any 
transcription or translational resources since no RNA or proteins need to be expressed. 
These features of decoy binding sites suggest their potential as a low fitness cost tool for 
metabolic engineering to redirect metabolic flux by selectively sequestering transcription 
factors.
 
1.3 Thesis overview 
The thesis is organized is four main chapters, each of which focuses on a different aspect 
of cellular burden.  In chapters 2 and 3, we focus on fitness cost and its effect on antibiotic 
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resistance machinery, using salicylate and marA as our model system. In chapters 4 and 5, 
we discuss fitness burden in metabolic engineering contexts and develop tools to lower the 
cost using arginine production as a show case.
 
In chapter 2, we find that salicylate can impose burdens for a wide spectrum of 
concentrations due to its induction of the resistance gene marA. In a mixed population of 
resistant and susceptible cells, salicylate increases the burden associated with resistant 
cells, but not their susceptible counterparts, leading to rapid exclusion of the resistant 
population. We also develop a mathematical model to capture the process and predict the 
population dynamics in different competitive settings.
 
In chapter 3, we explore the mechanism of the formation of persister, a subset of bacteria 
that acquire high antibiotic tolerant but exhibit slowed growth. We find that persister 
formation can be induced by salicylate. Salicylate-induced reactive oxygen species cause 
decreased membrane potential, reduced metabolic activity and lead to persister formation.
In chapter 4, we review the origin of cellular burden and cell-to-cell variation in metabolic 
engineering, and highlight recently developed strategies to control production 
heterogeneity and to ameliorate fitness cost in metabolic engineering to improve 
production. 
 
In chapter 5, we developed a synthetic tool that utilizes decoy transcription factor binding 
sites for redirecting metabolic flux. We find that decoy binding sites can effectively alter 
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expression of genes by “sponging” away free transcription factors and regulate metabolic 
pathway without detectable growth deficit.  
 
Collectively, this thesis explores the mechanisms and origins of fitness cost involves in the 
context of antibiotic resistance and metabolic engineering, and sheds light on strategies to 
exploit fitness cost to reverse antibiotic resistance or ameliorate costs to increase 




Chapter 2: Salicylate increases fitness cost associated with MarA-mediated 
antibiotic resistance 
2.1 Abstract 
Antibiotic resistance is generally associated with a fitness deficit resulting from the burden 
of producing and maintaining resistance machinery. This additional cost suggests that 
resistant bacteria will be outcompeted by susceptible bacteria in conditions without 
antibiotics. However, in practice this process is slow due in part to regulation that 
minimizes expression of these genes in the absence of antibiotics. This suggests that if it 
were possible to turn on their expression, the cost would increase, thereby accelerating 
removal of resistant strains. Experimental and theoretical studies have shown that 
environmental chemicals can change the fitness cost associated with resistance and 
therefore have a significant impact on population dynamics. MarA (multiple antibiotic 
resistance activator) is a clinically important regulator in Escherichia coli which activates 
downstream genes to increase resistance against multiple classes of antibiotics. Salicylate 
is an inducer of MarA which can be found in the environment and de-represses marA’s 
expression. In this study, we sought to unravel the interplay between salicylate and the 
fitness cost of MarA-mediated antibiotic resistance. Using salicylate as a natural inducer 
of MarA, we found that a wide spectrum of concentrations can increase burden in resistant 
strains compared to susceptible strains. Induction resulted in rapid exclusion of resistant 
bacteria from mixed populations of antibiotic resistant and susceptible cells. A 
mathematical model captures the process and predicts its effect in various environmental 
conditions. Our work provides a quantitative understanding of salicylate exposure on the 
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fitness of different MarA variants, and suggests that salicylate can lead to selection against 
MarA-mediated resistant strains. More generally, our findings show that natural inducers 
may serve to bias population membership and could impact antibiotic resistance and other 
important phenotypes. 
2.2 Introduction 
Antibiotic resistance is frequently associated with fitness deficits such as those resulting 
from burdensome expression of resistance proteins or from excessive energy consumption 
by resistance machinery (Marcusson, Frimodt-Møller and Hughes, 2009; Andersson and 
Hughes, 2010; Wood and Cluzel, 2012; Turner and Dunlop, 2015; Hernando-Amado et al., 
2017). These observations suggest that in the absence of antibiotic pressure, a bacterial 
population should be biased away from drug resistance (Levin et al., 1997; Levin, 2002; 
De Gelder et al., 2004). In practice, compensatory mutations and precise regulation of 
burdensome protein expression reduce the effective cost, largely eliminating the fitness 
differences. For example, in an antibiotic-free environment, tetracycline resistant bacteria 
that express the costly TetA efflux pump are expected to be outcompeted by susceptible 
strains (‘Effects of carriage and expression of the Tn10 tetracycline-resistance operon on 
the fitness of Escherichia coli K12.’, 1989). However, experiments have shown that the 
fitness cost of tetracycline resistance without antibiotic pressure is minimal (Levin et al., 
1997; De Gelder et al., 2004). Tight repression of tetA by TetR keeps costs low in the 
absence of inducers. These regulatory approaches to reducing cost are common, and other 
examples include repression of the multiple antibiotic resistance activator marA by MarR 
(Cohen, Hachler and Levy, 1993) and the multi-drug efflux pump acrAB by AcrR (Ma et 
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al., 1996). However, certain environmental chemicals can serve as inducers that relieve 
repression, and may change the fitness of antibiotic resistant bacteria. 
 
Environmental inducers include both the substrates that these mechanisms protect against 
(e.g. antibiotics) and other compounds. For example, the tetracycline decay product 
anhydrotetracycline (aTc) (Palmer, Angelino and Kishony, 2010), which is found widely 
in soil and wastewater (Sarmah, Meyer and Boxall, 2006; Jia et al., 2009), significantly 
increases the fitness cost of tetracycline resistant cells by releasing repression by TetR. The 
presence of aTc will select against resistant cells in the absence of antibiotic pressure 
because TetA is costly, but provides no benefit (‘Effects of carriage and expression of the 
Tn10 tetracycline-resistance operon on the fitness of Escherichia coli K12.’, 1989; Palmer, 
Angelino and Kishony, 2010). Other environmental chemicals such as food preservatives 
(Creamer et al., 2017) and pharmaceutical products (Wood and Cluzel, 2012) can impose 
fitness disadvantages by inducing higher levels of expression of resistance genes, which 
may lead to their eventual loss. A recent study demonstrated this effect by growing E. coli 
for 2000 generations in the presence of benzoate, an inducer for multiple antibiotic 
resistance genes. The majority of benzoate-evolved strains acquired mutations in marA and 
its homolog rob, thereby lowering resistance against chloramphenicol and tetracycline 
(Creamer et al., 2017).  
 
MarA is a clinically important antibiotic resistance regulator conserved across enteric 
bacteria (Cohen et al., 1993). It increases resistance levels by regulating over 40 
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downstream genes (Martin and Rosner, 1995, 2002, 2004; Martin et al., 1996, 2008; 
Barbosa and Levy, 2000; Grkovic, Brown and Skurray, 2003), including multi-drug efflux 
pumps and porins (Rosner, Chai and Foulds, 1991; Ma et al., 1995). Activation of these 
genes is taxing, resulting in decreased growth and a reduced fraction of cells with elevated 
MarA in a mixed community (Wood and Cluzel, 2012; Turner and Dunlop, 2015). 
However, marA is under the control of its repressor MarR, which minimizes the cost in the 
absence of induction (Martin and Rosner, 1995). MarA can also be modulated by its 
environmental inducer salicylate (Barbosa and Levy, 2000; Wood and Cluzel, 2012), 
which binds directly with MarR and prevents repression of marA (Cohen et al., 1993), 
significantly decreasing growth (Wood and Cluzel, 2012), which suggests an intriguing 
interplay between this environmental inducer and the cost of resistance machinery.  
 
In this work, we focused on the cost of MarA-mediated resistance under salicylate 
exposure. We found that a wide range of concentrations of salicylate can induce MarA-
mediated burden. AcrAB-TolC efflux pumps were found to be a major contributor to the 
salicylate-induced burden. The difference in cost under salicylate exposure leads to rapid 
exclusion of resistant strains in competitive settings. A mathematical model captures the 
process by which populations are biased away from resistance and predicts its effect in 
various salicylate conditions. This work suggests that the fitness cost of MarA-mediated 






MarA-mediated antibiotic resistance is costly 
In order to investigate MarA-mediated resistance, we employed three strains of E. coli: one 
where MarA and its homologs Rob and SoxS are knocked out (denoted MarA-) (Chubiz, 
Glekas and Rao, 2012), wild type (WT), and a strain where MarA is over-expressed via 
mutations in the MarR binding sites on its own promoter (MarA+). To verify that these 
strains exhibit differences in antibiotic resistance, we first measured the minimum 
inhibitory concentration (MIC) of carbenicillin. As expected, we found that the MIC 
increases as MarA expression levels increase (Fig. 2-S2). 
 
To quantify the cost of MarA-mediated resistance, we measured the growth of MarA-, WT, 
and MarA+ strains in LB medium without antibiotics and used fits to the Gompertz model 
(Eq. 1) to extract parameters associated with growth from the data: growth rate (µ), lag 
time (𝜆), and carrying capacity (A) (Zwietering et al., 1990) (Fig. 2-1a). The exact growth 
rate values derived from the Gompertz model are likely to be sensitive to temporal 
resolution of the measurements, which will impact their exact numerical values. In this 
work, we were primarily concerned with relative growth rates and use identical 
measurement resolutions for experiments where we fit the data. We found that, of the three 
model parameters, only the growth rate was strongly dependent on MarA expression levels 




To evaluate whether these differences in growth rates could alter the proportion of bacteria 
with different MarA expression levels in a mixed population, we carried out competition 
assays between MarA- and either WT or MarA+ strains under antibiotic-free conditions 
(Fig. 2-1c).  
 
To confirm and visualize the growth rate differences in the strains we integrated a gene 
encoding green fluorescent protein (sfgfp) into the genome of MarA-, and quantified the 
compositions of the mixed populations by flow cytometry (Methods, Fig. 2-S1). With 
initially equal representation between the strains, we found that the MarA- strain outgrew 
MarA+ but not WT in a short time window (4 h). In a longer competition (24 h), the MarA- 
strain outcompeted both WT and MarA+ as expected due to the lack of burdensome MarA 
expression. The change in population composition is strongest between the antibiotic 
susceptible (MarA-) and antibiotic resistant (MarA+) strains (Fig. 2-1c), suggesting fitness 
differentials are amplified if MarA is overexpressed. As a control, we also competed WT 
cells with and without genomically integrated sfgfp and found that the strains showed equal 
fitness, as expected (Fig. 2-S4). The inverse relationship between MarA-mediated 
resistance and fitness supports the concept that differences in fitness cost could result in 




Figure 2-1. MarA-mediated resistance is costly. (a) MarA- growth curve with experimental and 
modeling data. Black solid line is a fit to the Gompertz model. Data points show experimental 
data from six biological replicates. Error bars show standard deviation. Three parameters are 
extracted from the Gompertz model: growth rate (𝜇), lag time (𝜆), and carrying capacity (A). (b) 
Growth rate extracted from the Gompertz model fits for each strain. Data points show mean 
values and standard deviation from at least four biological replicates. Lag time and carrying 
capacity values are shown in Fig. 2-S3. (c) Fraction of cells of each strain over time after 
competition between MarA- and either WT or MarA+, with initially equal proportions of the 
competing strains in well-mixed liquid cultures. Relative proportions were obtained using counts 
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of fluorescent cells from flow cytometry. Error bars show standard deviation from three 
biological replicates. NS (Not Significant); *P <0.05; **P <0.01; ***P <0.001, Student’s t-test.  
 
Salicylate increases fitness cost in resistant strains compared to susceptible strains 
Since MarA expression is costly, we reasoned that inducing its expression with salicylate 
should accelerate the process of biasing the population toward strains that lack MarA 
expression. To test this, we first measured expression from the marA promoter induced 
with various concentrations of salicylate (Fig. 2-S5a). Using transcriptional reporters for 
marA in WT cells, we observed a clear trend of increased expression as the salicylate 
concentration increased. We then measured the cost of MarA expression induced by 
salicylate. As expected, increasing salicylate dosages have a clear negative impact on the 
growth of WT cells (Fig. 2-2a). However, the salicylate growth reduction effect can also 
be observed in the MarA- strain (Fig. 2-2b), which has marA and its homologs deleted. 
This suggests that salicylate can also reduce growth in a MarA-independent manner, 
possibly due to global effects such as by inhibiting expression of ATP synthase 
(Pomposiello, Bennik and Demple, 2001), decreasing membrane potential (Setty, Hendler 
and Shrager, 1983), or reducing metabolic activity (Wang, El Meouche and Dunlop, 2017). 
 
Since salicylate can increase antibiotic resistance and decrease cell growth, in order to 
measure the costs and benefits of salicylate induction, we further measured the dose-
response curve between carbenicillin and salicylate in the WT strain (Fig. 2-S6). We 
observed a severe reduction in growth at high concentrations of salicylate (5mM) in the 
absence of antibiotics, indicative of costs imposed by salicylate exposure. However, the 
	
	 21	
cells have a growth benefit from salicylate induction when the carbenicillin concentration 
is higher than 10 µg/ml, suggesting a trade-off between benefits and costs of salicylate 
induction.  
 
We next asked whether salicylate could increase the cost in strains with MarA expression 
(WT and MarA+) relative to the MarA- strain. To do this, we compared the relative growth 
rates between MarA- with either WT or MarA+, measured by the ratio of the growth rates 
between the two strains in increasing concentration of salicylate (Fig. 2-2c). Surprisingly, 
we found a weak positive correlation between relative growth rate and salicylate 
concentration in MarA- vs. MarA+, but not in MarA- vs. WT. Note that MarA+ cannot 
respond to salicylate via the native repressor MarR due to mutations in its MarR binding 
sites, indicating that this response to salicylate involves factors beyond MarA 
overexpression, potentially through induction of the MarA homolog Rob (Chubiz, Glekas 
and Rao, 2012). We also observed similar effects using fits to a Hill function (Wood and 
Cluzel, 2012) to quantify the growth cost in different strains as a function of salicylate 





Figure 2-2. Salicylate increases fitness cost of resistant strains. (a) Growth curves of WT strain 
under increasing salicylate concentrations. Solid lines show Gompertz model fits. For 
experimental data, error bars show standard deviation from four biological replicates. (b) Growth 
rates extracted from the Gompertz model for different strains at a range of salicylate 
concentrations show strain-specific trends between growth rate and salicylate concentration. Data 
points and error bars show experimental data from at least four biological replicates. (c) Relative 
growth rates between strains at increasing salicylate concentrations. Data points show ratio of 
mean growth rate between two strains. Dashed lines show linear least squares fit. Slope and its 
95% confidence interval (in parenthesis) of the linear fit are: 0.1196 (0.0958, 0.1433) for µAcrB-
/µMarA+; 0.0760 (0.0500, 0.1021) for µAcrB-/µWT; 0.0300 (0.0201, 0.0398) for µMarA-
/µMarA+; 0.0051 (-0.0125, 0.0226) for µMarA-/µWT. 
AcrAB-TolC efflux pump is a major contributor to MarA-mediated resistance burden 
We next asked where the cost of salicylate-induced MarA burden was coming from. MarA 
regulates many downstream genes, but the AcrAB-TolC efflux pump is known to play a 
critical role in resistance and imposes a significant energy cost (Turner and Dunlop, 2015). 
A transcriptional reporter for acrAB also showed that acrAB transcription can be induced 
by salicylate (Fig. 2-S5b). To test its role in salicylate-induced burden, we constructed 
AcrB-, an acrB knockout strain that renders the efflux pump nonfunctional. We also 
observed lower MIC values in AcrB- compared to WT or MarA+ (Fig. 2-S2).  
We measured growth rate of AcrB- with MarA+ and WT and compared it under various 
concentration of salicylate (Fig. 2-2b). Interestingly, salicylate has only a modest effect on 
the growth rate of AcrB- below 2.5 mM concentrations. We also observed a positive linear 
relationship between salicylate and the relative growth rate of AcrB- with WT and MarA+ 
(Fig. 2-2c). These results demonstrate that salicylate imposes less burden if the efflux pump 
is deleted. It is important to note that the AcrB- strain has intact copies of MarA and its 
homologs. Thus, AcrB- can still respond to salicylate exposure through MarA and its 
homologs, but the cost will not be increased in low salicylate concentrations if AcrAB-
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TolC cannot be produced. These results suggest that salicylate can induce much higher 
burden in the resistant strain (MarA+) than in the susceptible strain (MarA-), and this burden 
is mainly contributed by the AcrAB-TolC efflux pump. 
Salicylate accelerates competitive exclusion of resistant bacteria  
We next sought to test whether using salicylate to increase the relative cost in the resistant 
strain (MarA+) accelerates its exclusion in competitive environments. Since we found 
AcrAB-TolC to be largely responsible for the salicylate induced fitness cost, we first 
measured competitive exclusion between AcrB- and MarA+. Using an AcrB- strain with 
genomically integrated sfgfp, we measured the fraction of AcrB- and MarA+ cells by flow 
cytometry and the growth of the competition culture using a plate reader.  
 
In the absence of salicylate, small differences in growth rates are enough to allow the 
susceptible strain AcrB- to out compete the resistant strain MarA+, although the exclusion 
effect is not large (Fig. 2-3a). When the salicylate dosage was raised to 0.6 mM, the fraction 
of AcrB- cells increased because salicylate reduces the growth of the resistant strain MarA+ 
without imposing a significant impact on the susceptible strain AcrB- (Fig. 2-3b). This 
difference is further magnified at higher levels of salicylate exposure (Fig. 2-3c).  
 
To predict the competition dynamics between strains in different concentration of salicylate, 
we employed a mathematical model that we fit to the single-species growth rate (µ) and 
carrying capacity (A) data and used it to predict two-species competition under various 
salicylate conditions. The growth rates and carrying capacities calculated from single-
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species growth curves fit using the Gompertz model were applied to a Lotka-Volterra 
model for competitive growth (Eqs. 2-3). The model shows good agreement with the 
experimental data in the dynamics of both growth and the population fraction for each 
strain (Fig. 2-3a-c).  
We observed similar effects with salicylate when competing WT with AcrB- (Fig. 2-3d) 
and MarA- (Fig. 2-3e). However, competition between WT and MarA+ in salicylate did not 
lead to accelerated competitive exclusion (Fig. 2-3f). Since salicylate can significantly 
decrease bacterial growth (Fig. 2-2b), we verified that our results were not an artifact of 
differences in growth rate by calculating the selection coefficients during competition 
between WT and all mutants under salicylate exposure (Fig. 2-S8). The selection 
coefficient takes into account growth differences at higher salicylate concentrations 
(Dykhuizen, 2003). We observed similar trends in selection coefficients and results with 
cell counts, where AcrB- and MarA- have significantly higher finesses compared with WT 





Figure 2-3.  Salicylate accelerates competitive exclusion of resistant bacteria. Competitions of 
AcrB- (blue) with MarA+ (red) in (a) 0 mM (b) 0.6 mM, and (c) 5 mM salicylate seeded with 
initially equal populations. The red and blue shaded areas represent the predicted growth of each 
subpopulation using the Lotka-Volterra model, with the total area representing the combined 
population growth. Competitions of WT with (d) AcrB-, (e) MarA-, and (f) MarA+ in various 
concentrations of salicylate seeded with initially equal populations. Relative competitive fitness 
was measured by dividing cell counts of each mutant (NAcrB-, NMarA-, or NMarA+) by cell counts of 
WT (NWT). Cell counts were obtained by counting fluorescent cells from flow cytometry. Strains 
with genomically integrated sfgfp are AcrB- in (a-d), MarA- in (e), and WT in (f). Data points 
show mean values and standard deviation from three biological replicates. *P<0.05; **P<0.01; 
***P<0.001, Student’s t-test. 
 
Reducing population fraction of resistant cells increases susceptibility to antibiotic 
exposure 
To study the impact of the fraction of resistant strains on antibiotic resistance of a 
population, we subjected mixed populations with different proportions of susceptible 
(AcrB- and MarA-) and resistant (MarA+) strains to a lethal dose of carbenicillin (50 𝜇g/mL) 
for four hours and then measured survival by counting the colony-forming units (CFU/ml). 
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cells in the culture (Fig. 2-4a-c). We found similar results in mixed populations with WT 
and its susceptible counterparts (AcrB- and MarA-) (Fig. 2-4d-e), although the scale of 
CFU/ml change is not as substantial as in mixed populations with susceptible and resistant 
strains. Decreasing the proportion of MarA+ can significantly reduce the antibiotic 
resistance of the population. This result supports our hypothesis that antibiotic resistance 
levels decrease when a susceptible strain out-competes a resistant strain. 
 
Figure 2-4. Reducing fraction of MarA+ (and WT) cells increases susceptibility to antibiotic 
killing. Colony-forming units (CFU/ml) of co-cultures of MarA+ with (a) WT, (b) AcrB-, and (c) 
and MarA-. Co-cultures of WT with (d) AcrB- and (e) MarA- after applying 50 𝜇g/mL 
carbenicillin for 4 hours. Data points show mean values and standard deviation from n ³ 3 
biological replicates. NS (Not Significant); *P <0.05; **P <0.01; ***P <0.001. Student’s t-test 
comparing against 100% MarA+ (a-c) or 100% WT (d-e). 
 
Modeling population shifts under salicylate treatment 
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In the real-world environment, susceptible mutants may only constitute a small proportion 
of cells. To study the population dynamics starting from a very small initial proportion of 
the susceptible strain, we next used the Lotka-Volterra model to make predictions about 
the effects of salicylate exposure on mixed populations of susceptible mutants with 
resistant and WT strains (Fig. 2-5).  
 
We simulated competitive exclusion by starting with various initial proportions of the 
susceptible strains (AcrB- or MarA-) in a mixed population with MarA+ or WT, and applied 
the model over the course of 60 generations (approximately 1 week in real time (De Gelder 
et al., 2004)). The model predicts that resistant bacteria (MarA+ or WT) will be out 
competed by their susceptible counterparts much more rapidly with salicylate exposure 
than under conditions without salicylate. For example, if the susceptible strain AcrB- 
initially comprises 0.01% of a mixed population with MarA+ (Fig. 2-5a), after 60 
generations more than 30% and 99% of MarA+ is excluded in the presence of 0.3 mM and 
5 mM salicylate, respectively. These results are in stark contrast to the conditions without 
salicylate, where less than 5% of the MarA+ can be out-competed by AcrB- with the same 
initial composition. Similar trends in population shifts are also observed under competion 
with the WT strain (Fig. 2-5c), or in a mixed population of MarA- with MarA+ or WT (Fig. 
2-5b,d). The model predicts that even with extremely low initial proportions, susceptible 
strains (AcrB- or MarA-) can outgrow MarA+ or WT and that salicylate accelerates this 




Figure 2-5. Mathematical modeling predicts salicylate can accelerate population shift towards 
antibiotic susceptible strains. Predicted population compositions of competitions between (a, b) 
susceptible strains (AcrB- or MarA-) and MarA+ or (c, d) susceptible strains (AcrB- or MarA-) and 
WT obtained by extending the Lotka-Volterra model over 60 generations. Lines represent the 
final population fraction of susceptible cells for a particular salicylate concentration. 
 
2.4 Discussion 
Antibiotic resistance mechanisms frequently impose a significant fitness cost, suggesting 
the potential for competitive exclusion of resistant strains. However, this process is usually 
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study combining mathematical modeling and experimental data predicted that it would take 
approximately 1.5 years to reverse tetracycline resistance by replacing 99.9% of the cells 
carrying the tetA resistance gene (De Gelder et al., 2004). However, in the natural 
environment, bacteria commonly interact with other chemicals that could potentially 
induce expression of resistance genes. Costs imposed by induction could bias population 
composition.  
 
Resistant mutants with MarA overexpression are commonly found in clinical E. coli 
antibiotic resistant isolates (Maneewannakul and Levy, 1996; Oethinger et al., 1998; 
Lindgren, Karlsson and Hughes, 2003; Baym et al., 2016). In addition, recent laboratory 
evolution studies have also found that MarR, a repressor of MarA, frequently mutates under 
antibiotic stress (Baym et al., 2016), suggesting that the MarA-mediated resistant mutant 
(MarA+) may be in abundance in environments with frequent antibiotic exposure.  
  
In this study, we sought to unravel the impact of salicylate exposure on MarA-mediated 
resistance cost. We establish a mathematical model to predict the population dynamics 
under different levels of salicylate exposure. We found that salicylate imposes a higher cost 
in MarA-mediated resistant strains (MarA+) than in susceptible (MarA- and AcrB-) strains. 
Competition assays between MarA+ and AcrB- showed a positive correlation between 
salicylate concentration and the relative fitness cost. This suggests that with higher 
salicylate induction, the relative fitness cost of resistant strains will increase, accelerating 
their competitive exclusion. Mathematical modelling also predicted mixed population 
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dynamics from single strain growth parameters, and confirmed the effectiveness of 
salicylate exposure on accelerating the population bias towards susceptible strains. The 
resulting lower proportion of resistant cells in the population leads to greater lethality to 
carbenicillin. We further explored the origin of salicylate-mediated cost, and found that the 
AcrAB-TolC efflux pump contributes to escalated fitness cost in MarA-mediated resistant 
strains.  
 
Other factors that might affect competitive exclusion include the effective concentrations 
of salicylate and other environmental chemicals. The physiological concentrations of 
salicylate in human circulating plasma have been measured and vary between 0.1 µM to 
0.5 mM (Creamer et al., 2017) overlapping with values we tested here (Fig. 2-5). Further 
research may enable understanding of the interplay between salicylate and other chemicals 
and their combinatorial effects. 
  
Our study indicates the potential for important interaction effects between environmental 
chemicals and population composition. Understanding the interplay between 
environmental chemicals and the cost of resistance may help to explain and predict the 
population dynamics of resistant bacteria in the environment. 
 




We used four strains in this research: wild type (WT), MarA-, MarA+, and AcrB-. We use 
E. coli MG1655 as the WT strain. In the MarA- strain, we deleted the marRAB operon, rob 
gene, and soxSR genes from E. coli MG1655 (Wang, El Meouche and Dunlop, 2017). In 
the MarA+ strain, we performed transversion mutations on MarR binding sites (Martin and 
Rosner, 2004) in the chromosomal marRAB promoter to inhibit binding of MarR to the 
promoter region in E. coli MG1655 (Wang, El Meouche and Dunlop, 2017) . Further 
details on the deletion and transversion strains are given in Ref. (Wang, El Meouche and 
Dunlop, 2017). The AcrB- strain was derived from the Keio collection JW0451 (BW25113 
ΔacrB::kan) and we removed the kanamycin resistance marker, details described in Ref. 
(Langevin and Dunlop, 2018).  
 
For strains where we inserted the chromosomal fluorescent protein marker, we replaced 
the galK gene with sfgfp driven by a strong constitutive promoter as reported in (Siu et al., 
2018). We generated a PCR fragment of the constitutive promoter-driven sfgfp with 
extensions homologous to the regions adjacent to the galK gene. We used the forward 
primer: TTC ATA TTG TTC AGC GAC AGC TTG CTG TAC GGC AGG CAC CAG 
CTC TTC CGa gag gat cga gtt atc aaa aag a, and the reverse primer: TGC GCG CAG TCA 
GCG ATA TCC ATT TTC GCG AAT CCG GAG TGT AAG AAA TGg agt ttg gat ccc 
tat tat ttg ta. Capitalized letters indicate the homologous recombination extensions. We 
then followed the recombination protocol in Ref. (Datsenko and Wanner, 2000). After 
recombination, galK deleted colonies were selected using the counter selection method 




Minimum inhibitory concentration 
Overnight cultures of WT, MarA-, MarA+, and AcrB- were diluted 1:100 in LB medium. 
Diluted cultures were incubated at 37°C with 200 rpm shaking for 4 hours. Cells were then 
incubated with carbenicillin (0 to 50 µg/ml in 2-fold dilutions) at 37°C for 24 hours with 
200 rpm shaking. The minimum inhibitory concentration was determined as the 
concentration of antibiotic where no visible growth was observed. 
 
Bacterial growth conditions 
For all growth experiments, overnight cultures inoculated from a single colony were diluted 
1:500 in LB medium. The diluted cultures were then pre-cultured for 3 hours at 37°C with 
shaking at 200 rpm. We refer to the end of this pre-culture as time point t = 0 hours. 
Salicylate was added at t = 0 hours when required, we then continued culturing at 37°C 
with 200 rpm shaking. OD660nm readings were taken using a BioTek Synergy H1m plate 
reader each hour. 
  
Competition experiments 
For the competition experiments, each of two strains were cultured overnight separately, 
then diluted 1:1000 in fresh LB medium. Competition co-cultures were created by mixing 
cultures of each of two strains together in equal proportion. Co-cultures were then 
precultured for 3 hours, then at t = 0 salicylate was added where required, as in Ref. (Wood 
and Cluzel, 2012). OD660nm readings were taken each hour using the plate reader. In 
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addition, immediately following OD660nm measurements, 5 µl of the sample was diluted 
into 200 µl sterile phosphate-buffered saline (PBS) and we measured fluorescent protein 
expression with a Guava easyCyte HT flow cytometer. Flow cytometry data were analyzed 
with custom Matlab scripts. Control experiments using strains without green fluorescent 
protein expression were carried out to determine the threshold for strain classification (Fig. 
2-S1). 
 
Antibiotic killing experiments 
Cultures for antibiotic killing experiments were created by diluting overnight cultures of 
each of the strains at the percentages shown in Fig. 2-4. Overnight cultures of each strain 
were first diluted 1:1000 in fresh LB medium, pre-cultured for 3 hours at 37°C with 200 
rpm shaking, then strains were mixed together at percentages as specified in the figure axis. 
50 µg/ml of carbenicillin was then added to the co-cultures at t = 0. Cells were then 
centrifuged and resuspended in PBS to wash out the antibiotics. Washed cultures were 
diluted and plated on LB agar for 24 hours in order to determine the number of colony-
forming units per milliliter (CFU/ml) after antibiotic exposure. 
 
Dose-response experiments 
Overnight cultures of the WT strain were diluted 1:50 in LB medium with 0, 0.6, 1.2, and 
5mM salicylate. Diluted cultures with various concentration of salicylate were then pre-
cultured for 3 hours at 37°C with 200 rpm shaking. Cells were then incubated with 
carbenicillin (0 to 50 µg/ml in 2-fold dilutions) at 37°C for 4 hours with 200 rpm shaking. 
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OD660nm readings were taken using the plate reader four hours after carbenicillin exposure 
to determine cell density. 
 
marA and acrAB transcriptional reporters 
We used marA and acrAB transcriptional reporters in the WT strain to measure their 
transcriptional activity upon salicylate exposure. As described in Ref. (Rossi, Meouche and 
Dunlop, 2018), the promoter region of each gene was cloned upstream of the gene for cyan 
fluorescent protein (cfp) on a low-copy (SC101 origin) plasmid. Salicylate was added at t 
= 0. The reporter fluorescence level was measured using microscopy after 3 hours of 
salicylate exposure. Fluorescence distributions were calculated using kernel density. 
 
Gompertz model 
All growth curves were fitted to the modified Gompertz model (Eq. 1) described in Ref. 
(Zwietering et al., 1990). Carrying capacity (A), growth rate (µ), and lag-time (λ) were 
determined by least-squares fitting to the mean of the experimental data using a custom 
Matlab script. 
 
OD660 = A ∗ exp -	− 𝑒𝑥𝑝 3	4∗5
6
∗ (𝜆 − 𝑡) + 1	<	=	 (1) 
Selection coefficient 
The selection coefficients were calculated using the regression model (Eq. 2) described in 




S = [𝑙𝑛 B(C)
B(D)
]/[t]	 (2) 
S is the selection coefficient; R(t) is the final competition ratio of mutants to the WT strain, 
R(0) is the initial competition ratio of mutants to WT strain; t is number of generations in 
the competition experiment, corresponding to the number of doublings of OD660nm 
observed (Shachrai et al., 2010). 
 
Lotka-Volterra model 
The modified Lotka-Volterra equations (Eqs. 3 & 4) from Ref. (Liu, Guo and Li, 2006) 













∗ [	𝐴O −	𝑁O − (𝛼 ∗ 	𝑁K)] (4) 
Ni is the cell density of strain i, µi is the maximum growth rate, Ai is the carrying capacity, 
α is the interaction matrix. We assumed no interaction between strains, α = 1. Both µi and 
Ai were determined using single strain experimental growth curve data fit to the Gompertz 
model, as described above. Long-time simulations for Fig. 2-5 assume dilution every 8 
generations to the initial cell density, modeling serial transfers. We assume that the 
generation time is 30 minutes in the laboratory environment. All simulations were 




2.6 Supplementary Information 
 
 
Figure 2-S1. Green fluorescence level of WT with and without genomically integrated sfgfp 
determined by flow cytometry. WT strain with and without sfGFP. Each dot represents a green 
fluorescence reading of one cell in a sample of 5000 cells by flow cytometry. Black and green 


























Figure 2-S2. Minimum inhibitory concentration of carbenicillin in MarA-, AcrB-, WT, and 
MarA+ strains. Error bars show standard deviation from six biological replicates. *P<0.05; 




Figure 2-S3. Lag time (λ) and carrying capacity (A) extracted from Gompertz model fits for 
each strain. Data points show mean values and standard deviation from six biological replicates. 






















































Figure 2-S4. Competition assay between WT strains with and without genomically 
integrated sfgfp. Fraction of cells of each strain over time after competition between the WT and 
WT (sfGFP) with initially equal proportions of the competing strains in a well-mixed liquid 
culture. Relative proportions were obtained using counts of each fluorescent cell from flow 





























Figure 2-S5. Fluorescence distributions from (a) marA reporter and (b) acrAB reporter in the 
WT strain with and without salicylate exposure.  
 
Figure 2-S6. Dose-response curve between carbenicillin and salicylate for the WT strain. 
Optical density of WT strain growing in cultures with carbenicillin and salicylate. Data points 
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Figure 2-S7. Growth cost of strains as a function of salicylate concentration. Growth cost is 
defined as the reduction of growth rate of cells treated with salicylate relative to untreated cells. 
Dashed lines are fits to a Hill function h(x) = xn/(Kn+xn), where K equals to the salicylate 
concentration which inhibits cell growth by 50%, as described in Ref (Wood and Cluzel, 2012). 
K=5.05 (3.45, 5.83) mM, n=2.04 (1.37, 4.26) for the AcrB- strain; K=3.40 (1.49, 4.07) mM, 
n=1.18 (0.87, 2.71) for the MarA- strain; K=2.92 (1.15, 3.88) mM, n=0.85 (0.55, 1.94) for the WT 
strain; K=2.44 (1.05, 2.67) mM, n=0.95 (0.85, 2.21) for the MarA+ strain. 95% confidence 
intervals from nonlinear least square fitting are listed in parentheses. Data points and error bars 
























Figure 2-S8. Selection coefficients as a function of salicylate concentration in the competition 
experiments between WT and (a) MarA-, (b) AcrB-, and (c) MarA+. The selection coefficients 
were calculated using the regression model described in Methods. Strains with genomically 
integrated sfgfp are MarA- in (a), AcrB- in (b) and WT in (c). Data points show mean values and 








































































Chapter 3: Bacterial persistence induced by salicylate via reactive oxygen species 
3.1 Abstract 
Persisters are phenotypic variants of regular cells that exist in a dormant state with low 
metabolic activity, allowing them to exhibit high tolerance to antibiotics. Despite 
increasing recognition of their role in chronic and recalcitrant infections, the mechanisms 
that induce persister formation are not fully understood. In this study, we find that 
salicylate, the active metabolite of aspirin, can induce persister formation in Escherichia 
coli via generation of reactive oxygen species (ROS). Salicylate-induced ROS cause a 
decrease in the proton motive force, reducing metabolism, and leading to an increase in 
persistence. These effects can be recovered by culturing cells in the presence of a ROS 
quencher or in an anaerobic environment. Our findings reveal that salicylate-induced 
oxidative stress can lead to persistence, suggesting that ROS, and their subsequent impact 
on the proton motive force, may play a broad role in persister formation. 
 
3.2 Introduction 
Persisters are highly tolerant cells that can survive lethal doses of antibiotics by entering a 
dormant state (Lewis, 2010). They play an important role in chronic and refractory 
infections because they can evade antibiotic treatment and re-establish the population after 
treatment has stopped (Fisher, Gollan and Helaine, 2017). In contrast to resistance caused 
by genetic changes, persisters are genetically identical to antibiotic susceptible cells. 
Persisters can be generated by toxin/antitoxin systems (Balaban et al., 2004), stringent 
response (Nguyen et al., 2011), and SOS response (Dörr, Lewis and Vulić, 2009; Dörr, 
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Vulić and Lewis, 2010). Recent studies have also suggested that there are other more 
general mechanisms, such as ATP depletion, by which persisters can be formed (Conlon 
et al., 2016). Persisters can be generated stochastically (Balaban et al., 2004; Maisonneuve, 
Castro-Camargo and Gerdes, 2013), but mounting evidence suggests that their formation 
can also be triggered by environmental stress, such as that caused by antibiotics or low 
nutrient conditions (Dörr, Lewis and Vulić, 2009; Dörr, Vulić and Lewis, 2010; Nguyen et 
al., 2011). These environmental stimuli affect major cellular processes such as replication, 
translation, and metabolism, leading to an increase in the fraction of persisters within a 
bacterial population. However, the mechanisms behind persister formation and the stresses 
that can cause it are only partially understood. 
 
Salicylate is the active metabolite of aspirin, which is widely used to reduce fevers, relieve 
pain, and is used as an anti-inflammatory and anti-clotting agent (Price, Lee and Gustafson, 
2000). It is found in plants (Sorek et al., 2007) and is also a key component in many skin 
care and hair products. Previous research has shown that salicylate has multiple effects on 
bacterial physiology (Barbosa and Levy, 2000). For example, it can inhibit bacterial growth 
and the expression of genes encoding ATP synthase subunits (Wu et al., 2012). However, 
its role in combination with antibiotics is nuanced because salicylate can induce low-level 
resistance through induction of the multiple antibiotic resistance activator MarA (Mosel et 
al., 2013). It is important to note that the resistance levels achieved through this pathway 
are typically well below the lethal concentrations of antibiotics (Vega et al., 2012). Here 
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we find that salicylate can also induce ROS, leading to an increase in bacterial persistence 
via a pathway that independent of MarA. 
 
A few recent studies have suggested that ROS can provide a protective effect against lethal 
doses of antibiotics by inducing bacterial persistence. However, the mechanisms behind 
this are not fully understood. For instance, the ROS inducer paraquat can increase antibiotic 
survival by overexpressing SoxS, and consequently the AcrAB-TolC efflux pumps it 
controls (Dwyer et al., 2014), though it is not clear whether the pumps are primarily 
responsible for this effect (Brynildsen et al., 2013). In addition, hydrogen peroxide has 
been used as a direct source of ROS where it offered protection against a lethal dose of 
ofloxacin (Wood and Cluzel, 2012). Paradoxically, ROS have also been reported to 
contribute to the lethality of fluoroquinolones, β-lactams, and aminoglycosides (Setty, 
Hendler and Shrager, 1983; Sanders, 1988). The ability of ROS to both protect and kill 
bacterial cells underscores the complex role that ROS can play in the bacterial response to 
antibiotics. 
 
In this work, we found that salicylate induces persistence via ROS. Salicylate exposure 
allows a subpopulation of cells to survive lethal doses of antibiotics in a MarA independent 
fashion. Our findings suggest a pathway by which salicylate induces persistence by 





Previous reports have shown that salicylate inhibits bacterial growth (Wood and Cluzel, 
2012), dissipates the proton motive force (Setty, Hendler and Shrager, 1983), and represses 
genes encoding ATP synthase subunits (Pomposiello, Bennik and Demple, 2001); 
therefore, we hypothesized that salicylate might also increase bacterial persistence by 
decreasing metabolic activity. 
 
In order to test our hypothesis, we treated mid-exponential phase cells with salicylate and 
then exposed them to lethal doses of bactericidal antibiotics. We first used the 
fluoroquinolone ciprofloxacin, which acts by inhibiting DNA replication (Sanders, 1988) 
and is effective in all cell growth phases, making it a classical antibiotic for persister 
isolation (Kwan et al., 2013). Using a lethal dose of ciprofloxacin (5 µg/ml, 40 × minimum 
inhibitory concentration), we quantified persister levels by measuring the fraction of cells 
that survived antibiotic exposure relative to cells prior to exposure. After six hours of 
antibiotic exposure, we observed an 11-fold increase in persisters in the salicylate treated 
cultures relative to the untreated cultures (Fig. 3-1A). This increase in persistence was not 
due to lower growth of cells treated with salicylate (Fig. 3-S1). In order to eliminate the 
possibility that cells were surviving antibiotic treatment by inducing transient resistance 
mechanisms we also measured survival rates 24 hours after antibiotic exposure, finding a 
32-fold increase in persisters in the salicylate treated conditions. These results confirmed 





To test the generality of our findings, we next exposed cells to the β-lactam ampicillin (100 
µg/ml, 20 × minimum inhibitory concentration). Ampicillin inhibits cell wall biosynthesis 
and is also widely used for persister isolation (Balaban et al., 2004; Kwan et al., 2013). Six 
hours after treatment with ampicillin, we observed a 10-fold increase in persisters; at 24 
hours this ratio increased to 20-fold.  
 
To eliminate the possibility that the surviving cells had acquired mutations conferring 
permanent antibiotic resistance, we plated >100 colonies isolated from our persister assay 
in conditions with and without ciprofloxacin or ampicillin, and found no colonies that were 
able to survive antibiotic exposure (Figs. 3-1C-D). This confirmed that the surviving 
colonies were not the result of mutations that conferred resistance, but rather were 
persisters.  
 
Salicylate is the canonical inducer of the marRAB operon and induction of MarA’s 
downstream genes is known to increase the minimum inhibitory concentration for multiple 
antibiotics. Although salicylate treated cells could tolerate higher doses of antibiotics, the 
effects were modest and the elevated resistance levels were well below the working 
concentrations we used in our persister isolation assays (0.12 vs. 5 µg/ml for ciprofloxacin 
and 5 vs. 100 µg/ml for ampicillin) (Fig. 3-1E-F). Therefore, we asked whether the increase 
in persisters was due to MarA and the downstream genes it controls, such as the AcrAB-




To test this, we constructed two strains: one where MarA and its homologs Rob and SoxS 
are knocked out (ΔmarRAB Δrob ΔsoxSR) and another where MarA is overexpressed 
(MarA+). In the MarA+ strain, the promoter driving the marRAB operon has both binding 
sites for MarR inactivated, mimicking the conditions where salicylate inactivates the MarR 
repressor, leading to overexpression of MarA. We confirmed that these new strains 
functioned as expected by measuring the minimum inhibitory concentration of 
ciprofloxacin and ampicillin. Relative to wild type, the minimum inhibitory concentration 
decreased in ΔmarRAB Δrob ΔsoxSR and increased in MarA+ (Fig. 3-1E-F) The minimum 
inhibitory concentration of the wild type strain with salicylate treatment increased to the 
level of the MarA+ strain for both antibiotics, though remained well below the working 
concentrations we used in our persister isolation assays.  
 
We next measured persister levels under lethal doses of ciprofloxacin and found that 
salicylate-induced persisters can be generated through a pathway that is independent of 
MarA. For ΔmarRAB Δrob ΔsoxSR and MarA+ strains, salicylate treatment still 
significantly increased persister levels compared to the untreated conditions (Fig. 3-1G). 
After 6 hours of ciprofloxacin exposure we observed a 6.1-fold increase in persisters in the 
ΔmarRAB Δrob ΔsoxSR strain and a 9.1-fold increase in the MarA+ strain. These results 





Figure 3-1:  Salicylate increases bacterial persistence independent of MarA. 
(A-B) Fraction of E. coli MG1655 surviving after 6 and 24 hours of (A) 5 µg/ml ciprofloxacin or 
(B) 100 µg/ml ampicillin treatment with and without 5 mM salicylate. Error bars show standard 
error of n = 3 biological replicates. (C-D) Surviving colonies from the 24-hour persister tests with 
salicylate in (A) and (B) were spotted on LB only plates or LB supplemented with (C) 5 µg/ml 
ciprofloxacin or (D) 100 µg/ml ampicillin. (E-F) Minimum inhibitory concentration of (E) 
ciprofloxacin and (F) ampicillin in wild type strain with and without 5 mM salicylate and in 
ΔmarRAB Δrob ΔsoxSR and MarA+ strains. Error bars show standard error from n ≥ 3 biological 
replicates. (G) Survival after 6 hours of 5 µg/ml ciprofloxacin treatment with and without 5 mM 
salicylate. Error bars show standard errors from n = 3 biological replicates. In (A), (B), and (G) 
we used the Student’s t-test to test for statistical significance. Comparisons are made relative to 
the untreated condition.   
 
Salicylate is known to decrease the proton motive force in mitochondria and bacteria 
(Setty, Hendler and Shrager, 1983). Decreasing the proton motive force is an important 
pathway by which bacterial persisters are formed. For example, previous research has 
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shown that the protonophore CCCP as well as some toxin/anti-toxin systems can increase 
persistence by this mechanism (Dörr, Vulić and Lewis, 2010; Kwan et al., 2013). We 
reasoned that salicylate-induced persisters could result from a decrease in the proton 
motive force. To test this, we used the cyanine dye DiOC2(3) which accumulates inside 
the cell when the proton motive force is intact and shifts its emission spectrum from red to 
green when the proton motive force is dissipated. We found that salicylate treatment caused 
a decrease in the proton motive force relative to untreated cells (Fig. 3-2A). The results 
were similar to those in the control group treated with CCCP (Fig. 3-2B). 
 
We next asked what caused the decrease in proton motive force. A prior study in 
mitochondria has shown that reducing reagents can recover a salicylate-included decrease 
in proton motive force, suggesting that ROS may play a role. To investigate this, we 
incubated cells with the reducing reagent dithiothreitol (DTT).  When we treated cells with 
both salicylate and DTT, we were able to recover the proton motive force (Fig. 3-2C). 
Recovery was not due to the action of DTT alone (Fig. 3-S2). In addition, DTT cannot 
recover the proton motive force decrease caused by CCCP, which dissipates proton motive 
force directly (not via ROS) by acting as a protonophore (Fig. 3-2D). This result establishes 
the direction of the effect: salicylate-induced ROS leads to a decrease in proton motive 
force.  
 
To further confirm this we measured ROS directly by labeling cells with the fluorogenic 
marker carboxy-H2DCFDA. Cells treated with salicylate showed elevated fluorescence, 
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reaching levels comparable to the positive control incubated with tert-Butyl hydroperoxide 
(TBHP) (Fig. 3-2E). These results are in agreement with a previously published finding 
showing that salicylate can increase ROS generation (Hao et al., 2014).  
 
Having established the connection between salicylate, ROS levels, and proton motive 
force, we next sought to link our findings to bacterial persistence. Because persistence is a 
state where metabolic activity is decreased, we constructed a reporter for metabolism using 
the rrnB P1 reporter, which measures the 16S rRNA transcriptional level (Shah et al., 
2006). We observed a decrease in rrnB P1 expression in the culture with salicylate, which 
indicates it can indeed decrease metabolism (Fig. 3-2F). Critically, the decreased 
metabolism levels due to salicylate can be recovered by co-treatment with DTT. DTT alone 
cannot increase metabolism, and in fact decreased metabolism relative to untreated cells. 
The recovery in metabolism due to the combined effect of salicylate and DTT suggests that 
the increase in persisters in salicylate-treated cultures is due to elevated ROS levels. We 
sought to test this directly by quantifying persister levels in cells treated with DTT alone 
and DTT with salicylate. Importantly, we found that salicylate could no longer increase 





Figure 3-2: Salicylate generates ROS, dissipates proton motive force, and reduces metabolism. 
(A-D) Red vs. green fluorescence scatter plots showing individual cells treated with the proton 
motive force indicator DiOC2(3) (A) With and without 5 mM salicylate. (B) With and without 5 
µM CCCP, a protonophore. (C) 5 mM salicylate with and without 100 mM DTT, a reducing 
reagent. (D) 5 µM CCCP with and without 100 mM DTT. (E) Green fluorescence divided by OD 
600nm  for cultures treated with the general ROS indicator carboxy-H2DCFDA. TBHP is a positive 
control for ROS. Error bars show standard deviation from n = 3 biological replicates. We used the 
Student’s t-test to test for statistical significance. (F) Fluorescence distributions from the rrnB P1 
reporter for wild type cells with and without 5 mM salicylate, with 100 mM DTT, and with both 5 
mM salicylate and 100 mM DTT. (G) Survival after 6 hours of 5 µg/ml ciprofloxacin treatment in 
the presence of 100 mM DTT with and without 5 mM salicylate. Error bars show standard errors 
from n = 3 biological replicates. 
 
To further confirm our hypothesis that salicylate induces persisters via production of ROS, 
we measured persister levels using ciprofloxacin in a strict anaerobic environment.  
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environment (Fig. 3-3A). This was the case both with and without fumarate, an alternative 
electron acceptor. Results under anaerobic conditions with ampicillin were similar (Fig. 3-
S3). We further confirmed the link between ROS and persister formation by treating cells 
with 120 µM H2O2 followed by 6 or 24 hours of ciprofloxacin exposure (Fig. 3-3B). We 
found that treatment with H2O2 increased persistence in both cases, highlighting the 
important role of ROS in bacterial persistence. 
 
 
Figure 3-3: Salicylate-induced persistence requires oxygen.  
(A) Survival with and without 5 mM salicylate after 6 hours of 5 µg/ml ciprofloxacin treatment 
under anaerobic conditions with and without 40 mM fumarate, an alternative electron acceptor. 
Error bars show standard errors from n = 3 biological replicates. (B) Survival after 6 and 24 hours 
of 5 µg/ml ciprofloxacin treatment with and without 120 µM H2O2 as a positive control for 
oxidative stress. Error bars show standard errors from n = 3 biological replicates. We used the 























































Here, we showed that salicylate increased bacterial persistence up to 32-fold under lethal 
doses of bactericidal antibiotics. Although salicylate has a known role for induction of 
antibiotic resistance through MarA (Cohen et al., 1993; Price, Lee and Gustafson, 2000), 
the effect is modest and far below the concentrations of antibiotics we used in this study. 
Bacterial persistence is a more insidious problem than low-level antibiotic resistance, 
because a small number of persisters can evade antibiotic treatment and go onto recolonize 
after antibiotics treatment has stopped.  
 
Our results suggest that the increase in persistence is due to an increase in ROS that causes 
a decrease in proton motive force and metabolism (Fig. 3-3C). These results are consistent 
with previous transcriptional studies showing that salicylate can repress translation 
machinery and ATP synthesis genes (Barbosa and Levy, 2000). Furthermore, oxidative 
stress genes like the superoxide dismutase sodA are up-regulated upon salicylate exposure 
(Barbosa and Levy, 2000). Here, we found that the ROS quencher DTT was able to recover 
the metabolism levels that were decreased by salicylate. It also recovered the proton motive 
force and eliminated the effect of salicylate on persister levels. In a parallel set of 
experiments, we confirmed the role of ROS by growing cells in anaerobic conditions, 
which eliminated the protective effect of salicylate as well. These findings reveal that 
salicylate can induce persistence and also present a new pathway by which ROS can 




There are multiple mechanisms by which ROS may contribute to the formation of persister 
cells. For example, ROS have been shown to induce efflux pumps via SoxS (Wu et al., 
2012). Although efflux pump expression can contribute to persister formation (Pu et al., 
2016), other studies have shown that superoxide can also protect cells from the action of 
antibiotics even in an efflux pump deficient strain (Mosel et al., 2013). Thus, efflux pumps 
are not the only mechanisms that provide protection under lethal doses of antibiotics. 
Moreover, bacterial communication and molecular signaling can lead to increased 
persistence via oxidative stress responses (Vega et al., 2012). The role of ROS in antibiotic 
tolerance and resistance is complex, with recent examples of cases where they are 
beneficial (Vega et al., 2012; Wu et al., 2012; Mosel et al., 2013), neutral (Keren et al., 
2013; Liu and Imlay, 2013), or even detrimental (Brynildsen et al., 2013; Dwyer et al., 
2014). Investigations on the effect of ROS in antibiotic resistance, and in particular their 
role in persistence, remain a rich area for future study. Our results here highlight the 
importance of ROS in bacterial persistence induced by salicylate and suggest that 
monitoring ROS levels may provide critical information for understanding persister 
formation. 
 
3.5 Materials and Methods 
Bacterial strains and growth conditions 
E. coli K-12 MG1655 was cultured in Luria Bertani (LB) medium at 37°C. The subsequent 




ΔmarRAB Δrob ΔsoxSR strain 
We deleted the marRAB operon, rob gene, and soxSR genes using homologous 
recombination. Primers and further details are provided in Supplementary Methods. 
 
MarA+ strain 
The MarA+ strain has the chromosomal copies of the two MarR binding sites in the 
marRAB promoter inactivated, removing negative feedback by MarR. We based the design 
on transversion mutations from. Further details are provided in Supplementary Methods. 
 
Persister assays 
Cultures were grown aerobically at 37°C with shaking at 200 rpm overnight and then 
diluted 1:100 in LB medium. We refer to the time of this dilution as t = 0 hours. The diluted 
cultures were incubated until t = 3 hours so that cultures reached mid-exponential phase 
(OD 600nm = 0.8 to 1.0). For treated conditions, at t = 2.5 hours we added 5 mM salicylate 
(Thermo Fisher Scientific S396-500), 120 µM H2O2 (J. T. Baker #220401), or 100 mM 
DTT (Thermo Fisher Scientific #AC165680010). At t = 3 hours aliquots from each culture 
were diluted and plated on LB agar in order to determine the number of colony forming 
units before antibiotic exposure. We then added 5 µg/ml ciprofloxacin or 100 µg/ml 
ampicillin and cultures were incubated for either 6 or 24 hours (t = 9 or 27 hours). Cells 
were then centrifuged and resuspended in sterile phosphate-buffered saline (PBS) to wash 
out the antibiotics. Washed cultures were diluted and plated on LB agar for 24 hours in 
order to determine the number of colony forming units after antibiotic exposure. We 
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checked for resistant mutants among the surviving cells by spotting >100 colonies on LB 
agar and LB agar supplemented with 5 µg/ml ciprofloxacin or 100 µg/ml ampicillin. 
 
Determining the minimum inhibitory concentration of ampicillin and ciprofloxacin 
Overnight cultures of E. coli MG1655, ΔmarRAB Δrob ΔsoxSR, and MarA+ were diluted 
1:100 in LB medium. The diluted cultures were incubated at 37°C with shaking until t = 8 
hours. The OD 600nm of each culture was then normalized to start new cultures in the 
presence of antibiotics and 5 mM salicylate, when required. Cells were incubated with 
increasing concentrations of ciprofloxacin (0 to 0.5 µg/ml in 2-fold dilutions) or ampicillin 
(0 to 20 µg/ml in 2-fold dilutions) at 37°C for 24 hours with shaking. The final OD 600nm 
was then determined and cell growth was considered inhibited if OD 600nm < 0.1. 
 
Proton motive force measurements 
We used the BacLight™ Bacterial Membrane Potential Kit (Invitrogen #B34950) to 
measure the proton motive force. Overnight cultures were diluted 1:100 in LB medium and 
cultured until t = 3 hours. We used the following conditions for the cultures with treatment: 
5 mM salicylate was added at t = 1.5 hours, 100 mM DTT was added at t = 2.5 hours, and 
5 µM CCCP (R&D Systems #0452500) was added at t = 2.75 hours. The timing of 
salicylate and DTT treatments were selected to optimize detection while minimizing the 
impact on cell growth; CCCP timing follows guidelines from the BacLight™ kit. Samples 
were analyzed using flow cytometry with settings according to the kit instructions to 




Reactive oxygen species assay 
For the ROS measurements we used the Molecular Probes™ Carboxy-H2DCFDA kit 
(Invitrogen #C400) according to the manufacturer’s instructions. Overnight cultures were 
diluted and cultured until t = 3 hours. 5 mM salicylate was added at t = 1 hour to allow for 
ROS accumulation, and 520 mM TBHP (Acros Organics #180345000) was added at t = 
2.25 hours following the protocol developed by Rutheford, et al.  Fluorescence was 
measured at 525 nm using a BioTek Synergy H1m plate reader 10 minutes after adding the 
dye. 
 
rrnB P1 reporter 
We amplified the promoter region of rrnB P1 from E. coli MG1655 using the forward 
primer GCCAGGAGCTGAACAATT and the reverse primer 
TGGTGGCGCATTATAGG. This promoter region was then cloned upstream of sfgfp 
(AddGene #63176) tagged with a ssrA degradation tag on the low-copy (SC101) plasmid 
pBbS5k from which the extraneous copy of lacI and its promoter have been removed. 
Kanamycin (30 µg/ml) was added to maintain the resistance marker. The reporter 
fluorescence level was measured using flow cytometry at t = 3 hours. For the cultures with 
treatment, we added either 5 mM salicylate and/or 100 mM DTT at t = 2.5 hours. After 
incubation, cultures were diluted in sterile PBS. Fluorescence levels were measured by 




Persister assay in anaerobic conditions 
Overnight cultures were diluted 1:100 in LB medium pre-incubated under anaerobic 
conditions using a gas mixture containing 85% N2, 5% CO2, and 10% H2. Diluted cultures 
with and without 40 mM fumarate (Acros Organics # AC215531000) were grown in the 
anaerobic chamber until t = 4 hours at 37°C to reach mid-exponential phase (OD600nm = 0.8 
to 1.0). Salicylate was added at t = 3.5 hours when required. Aliquots from each culture 
were taken before antibiotic exposure in order to determine the number of colony forming 
units. 5 µg/ml ciprofloxacin or 100 µg/ml ampicillin was then added to the cultures at t = 
4 hours and left until t = 10 hours. Cells were removed from the anaerobic chamber, 
centrifuged, and resuspended in sterile PBS to wash out the antibiotics. Samples were 
diluted, plated on LB agar, and incubated aerobically for 24 hours at 37°C.  
 
3.6 Supplementary Information 
Bacterial strains and growth conditions 
ΔmarRAB Δrob ΔsoxSR strain 
We generated a PCR fragment of the kanamycin resistant gene flanked by FRT regions 
from pKD13 with extensions homologous to the regions adjacent to the operon or gene.  
 
For deletion of the marRAB operon, we used the forward primer: 
CCAGCGATCTGTTCAATGAAATTATTCCATTGGGTCGCTTAATCCATATG
GTGTAGGCTGGAGCTGCTTC 






For deletion of the rob gene, we used the forward primer:  
CGACGGATCGGAATCAGCAGTTCACAGCGTAGATTAATTGGGCGATCTC
CGTGTAGGCTGGAGCTGCTTC  




For deletion of the soxSR genes, we used the forward primer:  
AATTACAGGCGGTGGCGATAATCGCTGGGAGTGCGATCAAACTGCCGAC
GGTGTAGGCTGGAGCTGCTTC    




Bold letters indicate the homologous recombination extensions. We then followed the 
protocol from using the phage lambda recombinase harbored on the low copy plasmid 
pSIM6. After recombination, the resistance marker gene was removed using the pCP20 





The transversion mutations were derived from, where they are listed as “TV -14 to -18” 
and “TV +11 to 15.” To construct this strain we synthesized a DNA fragment containing a 





Underlined letters indicate the MarR binding sites and bold letters indicate the transversion 
mutations. We introduced this modified promoter via homologous recombination 
following, then cured the resistance marker. To accomplish this, we ligated the modified 
marRAB promoter given above to the kanamycin resistance gene flanked by FRT regions 
from pKD13. The ligated fragment containing the kanamycin resistance gene followed by 
the modified marRAB promoter was then amplified using the forward primer: 
GGGGTAAACAAGGATAAAGTGTCACTCTTTAGCTAGCCTTGCATCGCAT
TGTGTAGGCTGGAGCTGCTTC and the reverse primer: 
AATAATTTCATTGAACAGATCGCTGGT.  
Bold letters indicate the homologous recombination extensions. We followed the protocol 








Figure 3-S1: Salicylate exposure does not affect initial cell counts before addition of antibiotics. 
Colony forming units per milliliter (CFU/ml) for cultures with and without 5 mM salicylate under 
aerobic conditions and anaerobic conditions before addition of antibiotics (t = 3 hours in aerobic 
conditions and t = 4 hours in anaerobic conditions). Error bars show standard errors from n = 12 











































Red vs. green fluorescence scatter plots showing individual cells treated with the proton motive 




Figure 3-S3: Salicylate-induced persistence in ampicillin requires oxygen.  
Survival with and without 5 mM salicylate after 6 hours of 100 µg/ml ampicillin treatment under 
anaerobic conditions with and without 40 mM fumarate. Error bars show standard errors from n = 





















No salicylate 5mM salicylate
	
	 63	
Chapter 4: Controlling and exploiting cell-to-cell variation in metabolic engineering 
4.1 Abstract 
Individual cells within a population can display diverse phenotypes due to differences in 
their local environment, genetic variation, and stochastic expression of genes. 
Understanding this cell-to-cell variation is important for metabolic engineering 
applications because variability can impact production. For instance, recent studies have 
shown that production can be highly heterogeneous among engineered cells, and strategies 
that manage this diversity improve yields of biosynthetic products. These results suggest 
the potential of controlling variation as a novel approach towards improving performance 
of engineered cells. In this review, we focus on identifying the origins of cell-to-cell 
variation in metabolic engineering applications and discuss recent developments on 
strategies that can be employed to diminish, accept, or even exploit cell-to-cell variation. 
 
4.2 Introduction 
As microscopy, flow cytometry, and other single-cell measurement technologies advance, 
researchers have begun to compare measurements of individual cells to bulk population 
averages. These studies have revealed that variability between cells can be significant, 
suggesting that population-level averages may obscure underlying heterogeneity (Eldar 
and Elowitz, 2010; Loewer and Lahav, 2011; Levine, Lin and Elowitz, 2013; Symmons 
and Raj, 2016). Cell-to-cell variation can be caused by many factors including genetic 
differences, phenotypic heterogeneity, and differences in the local microenvironment. In 
natural contexts, this type of variability can play an important functional role, such as 
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reducing burden of costly protein expression or increasing survival in changing 
environments (Davidson and Surette, 2008; Grimbergen et al., 2015; West and Cooper, 
2016). In this review, we discuss the origins of variation relevant to metabolic engineering 
and highlight recent examples of strategies to control diversity that hold promise for 
improving production yields. 
 
Despite the prevalence of cell-to-cell variation in nature, it is not traditionally studied in 
the context of metabolic engineering applications. The reasons behind this are practical, as 
it can be technically challenging to measure single-cell level effects, and reporters and 
methods for quantifying metabolically-relevant states often do not exist. However, the 
importance of understanding cell-to-cell differences is highlighted by recent metabolic 
engineering studies that have shown that cell-to-cell variation can impose a significant 
impact on production. For example, Xiao et al. demonstrated that 15% of cells in an 
isogenic Escherichia coli population of free fatty acid producers were responsible for over 
half of the total product (Xiao et al., 2016). In another study, approximately a third of cells 
in cultures of the production host Bacillus megaterium were shown to persist in a low 
production state, regardless of culturing conditions (Münch et al., 2015). These studies 
suggest that managing cell-to-cell-variation may offer a potential approach for further 
optimization of production pathways, which can be used in concert with traditional 




In this review, we discuss the origins of cell-to-cell variation in metabolic engineering and 
strategies to control variability. We divide the origins of variation into environmental and 
cellular categories, the latter of which includes variation due to native and engineered 
components, and the interplay between them. We then discuss strategies for controlling 
and exploiting variation in metabolic engineering contexts. These range from diminishing, 
to accepting, to actively creating variation within populations of cells. Finally, we describe 
technological advances that would help to facilitate quantification and the engineering of 
control strategies. 
 
4.3 Origins of cell-to-cell variation in metabolic engineering 
Cell-to-cell variation in metabolic engineering applications can be divided into two 
categories. First, environmental variation, which is due to the impact of gradients in local 
conditions, such as nutrient availability or extracellular product levels. Second, cellular 
variation, which is due to properties internal to the cell, such as heterogeneity in cellular 
resources or intracellular product levels (Fig. 4-1). 
 
Although we generally assume that production environments are homogeneous, several 
studies have demonstrated that this assumption is not entirely valid as volume scales are 
increased. Within industrial scale bioreactors, mixing becomes challenging due to high 
viscosities and large volumes (Heins and Weuster-Botz, 2018). Consequently, production 
variation can occur even within isogenic cell populations due to the fact that cells are 
exposed to different local conditions within the same bioreactor. Most approaches for 
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increasing homogeneity within scaled-up bioreactors are mechanical and aim to ensure 
even mixing (Lara et al., 2006; Takors, 2012), however it is also possible to design genetic 
circuits that work to mitigate the effects of this nonuniformity.  
 
Cellular variability is impacted by both native properties, such as ribosome and ATP levels, 
and heterologous factors, such as expression of a burdensome, non-native enzyme. In 
addition, diversity can arise due to the interplay between these native and engineered 
components. For instance, some cells may have a higher capacity for expression of a 
synthetic circuit than others due to single-cell level differences in transcription or 
translation machinery. 
 
Examples of endogenous sources of cell-to-cell variation are genetic diversity and 
phenotypic heterogeneity in expression of native pathways. Genetic diversity can arise 
from mutations accumulated during the production process, which can lead to production 
differences between cells (Rugbjerg et al., 2018). Alternatively, genetic differences may 
be specifically engineered, such as in applications that employ different stains or species 
in co-cultures for biosynthesis (Tsoi et al., 2018). In contrast to variation due to genetic 
changes, phenotypic heterogeneity, which is commonly referred to as “noise,” exists even 
in isogenic cells due to stochasticity in how genes are expressed (Elowitz et al., 2002). 
Phenotypic heterogeneity can have a major impact on the physiological state of the cell, 
and has been shown to affect growth rate, ATP levels, overall protein abundance, and 
metabolism in single cells (Taniguchi et al., 2010; Labhsetwar et al., 2013; Raser and 
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O’Shea, 2013; Kiviet et al., 2014; Shan et al., 2017). Endogenous variation ultimately 
impacts biosynthesis, leading to differences in production between cells. The addition of 
heterologous elements can further exacerbate cell-to-cell variation, as these components 
can impose burden, introduce toxicity, and redirect metabolic flux, thereby affecting native 
pathways (Zhang, Carothers and Keasling, 2012; Dahl et al., 2013; Xu et al., 2014; Siu et 





Figure 4-1. Origins of cell-to-cell variation in metabolic engineering. Sources of variation can be 
divided into environmental and cellular variation. Environmental variation originates from 
heterogeneity in the local environment, such as due to poor-mixing in a large-scale bioreactor. 
Cellular variation can result from both native and engineered pathways due to genetic diversity or 
phenotypic heterogeneity. Significant interplay exists between environmental and cellular 




4.4 Strategies for coping with cell-to-cell variation in metabolic engineering 
Depending on the circumstances, it may be advantageous to reduce variability, to design 





Figure 4-2. Strategies for coping with cell-to-cell variation in metabolic engineering. Depending 
on the circumstances, the optimal engineering strategy may be to diminish variation, accept 
variation but mitigate its negative impact, or create and exploit cell-to-cell variation.  
 
Diminishing variation 
Some variation in engineered constructs is a by-product of noisy regulatory elements. For 
example, the arabinose inducible PBAD promoter is commonly used to control gene 
expression. In the arabinose regulatory network, unequal expression of the transporters 
AraE and AraFGH can create heterogeneous expression from the PBAD promoter (Siegele 
and Hu, 1997). Cells with more transporters take up more arabinose and further induce 
transporter expression, forming a positive feedback loop which creates a bimodal 
distribution of cells with the PBAD promoter ON and OFF. Overexpressing AraE produces 
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more uniform PBAD promoter expression, effectively homogenizing the response 
(Khlebnikov et al., 2000, 2001). Similar response heterogeneity effects and homogenizing 
strategies have also been described for lactose/IPTG [29,30] and aTc [31,32] inducible 
promoters. These examples demonstrate how heterogeneity can be removed when native 
noisy regulatory elements are repurposed. 
 
Expression heterogeneity caused by differences in plasmid copy number is another source 
of variation relevant for metabolic engineering. Plasmid numbers can vary widely, even in 
clonal populations, due to stochastic fluctuations in partitioning and replication (Lin-Chao 
and Bremer, 1986; Wong Ng et al., 2010) and environmental perturbations (Lin-Chao and 
Bremer, 1986; Lin‐Chao, Chen and Wong, 1992). For example, a recent study on the 
production host B. megaterium found that asymmetric plasmid distribution was responsible 
for approximately 30% of the engineered cells existing in a low-production state 
(Biedendieck et al., 2007; Münch et al., 2015). The uneven distribution of plasmids can 
cause detrimental effects to both low and high copy number cells, where cells with fewer 
plasmids have decreased productivity, while those with more plasmids become overloaded, 
consequently ceasing growth and stopping production. Integrating pathways into the 
chromosome does not fully resolve the problem due to variation in single-cell replication 
states in fast dividing populations, which can result in genes located closer to the origin of 
replication having higher effective copy numbers (Chandler and Pritchard, 1975). A recent 
study developed a novel method for maintaining stable expression even in the face of 
varying copy number (Segall-Shapiro, Sontag and Voigt, 2018). Segall-Shapiro et al. 
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engineered incoherent feedforward loops in E. coli promoters using transcription-activator-
like effectors (TALEs) to detect changes in plasmid copy number and tune promoter 
activity accordingly. Promoters equipped with the genetic circuit were able to maintain 
constant expression despite widely varying plasmid copy numbers and environmental 
perturbations. 
 
More general methods that do not aim at any specific source of variation have also been 
developed to homogenize populations by isolating high-performing cells. Xiao et al. 
developed a population quality control circuit in E. coli for free fatty acid and tyrosine 
production that allows for continuous selection of high-producing variants (Xiao et al., 
2016). The genetic circuit links end-product synthesis with expression of the tetracycline 
resistance gene using a synthetic promoter controlled by a biosensor. The production 
reaction is conducted under conditions with tetracycline, thus low-production cells, which 
also exhibit low antibiotic resistance, are eliminated, leaving only high-production cells. 
Using this approach, the study achieved a four-fold increase in free fatty acid production 
and two-fold increase in tyrosine production over conditions without the selection. In a 
second example, Rugbjerg et al. built a genetic circuit in E. coli to link production of 
mevalonic acid with expression of the essential genes, glmM and folP, limiting growth of 
low-production cells (Rugbjerg et al., 2018). These strategies serve to homogenize the 
population and eliminate underperforming cells. 
 
Accepting variation and mitigating its detrimental impact 
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Due to the complex nature of cell-to-cell variation, it may not always be practical to 
homogenize the population. Instead, methods that accept the variation and mitigate its 
negative impact are often a strategic choice. Dynamic control strategies that combine gene 
circuits with biosensors can allow cells to respond to variation that arises from either 
engineered or native pathways, and fine-tune heterologous (and other) pathways to achieve 
individualized optimal production levels. For recent reviews on dynamic control, see (Tan 
and Prather, 2017; Lalwani, Zhao and Avalos, 2018; Xu, 2018). 
 
Intermediate and enzyme levels vary from cell to cell, thus an ideal production process will 
allow each individual cell to turn on production as substrates accumulate in order to achieve 
maximal efficiency. As an example, Zhang et al. developed a dynamic sensor-regulator 
system to allow engineered E. coli to sense the existence of acyl-CoA and then turn on a 
production pathway to convert this intermediate to fatty acid ethyl ester (Zhang, Carothers 
and Keasling, 2012). This method allowed cells to produce three-fold higher titers over 
those without the control system.  
 
Differences in heterologous enzymes, pathway intermediates, and end-product 
concentrations can also lead to cell-to-cell differences in the burden and toxicity imposed 
by the pathway. One way to mitigate this is to tune down expression when toxic compounds 
accumulate in each individual cell using dynamic control (Zhang, Carothers and Keasling, 
2012; Dahl et al., 2013; Xu et al., 2014). In addition to controlling production, it is also 
possible to turn on detoxifying mechanisms to cope with product accumulation. As an 
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example, Siu et al. developed a dynamic control strategy to counteract biofuel toxicity. 
When biofuel accumulates, the host cell turns on expression of an efflux pump to export 
biofuel, thereby increasing tolerance and growth (Siu et al., 2018). A recent review covered 
engineering strategies for tackling burden and toxicity of heterologous pathways (Gong, 
Nielsen and Zhou, 2017). 
 
Most dynamic control circuits are designed to cope with one specific type of burden due to 
the specificity of their biosensors. An alternative, more general approach is to sense and 
regulate the overall cellular burden rather than a particular product. Using RNA-seq to 
identify major transcriptional changes that occur during burdensome foreign protein 
expression, Ceroni et al. found that native promoters related to heat-shock response can 
actively respond to a wide range of heterologous pathway burdens, including expression 
of an inducible reporter, a large heterologous protein, and a metabolic pathway (Ceroni et 
al., 2018). The researchers used a dCas9-based feedback-regulation system to 
downregulate pathway expression in response to burden sensed by the heat shock 
promoters. Therefore host cells equipped with these controllers tune production based on 
an individual cell’s burden, instead of in response to a specific compound.  
 
In addition to dynamic control strategies that target variation that arises from the addition 
of engineered pathways, an alternative approach is to individualize control in cells based 
on their endogenous physiological states, such as based on the availability of ribosome 
(Shachrai et al., 2010; Ceroni et al., 2015) and RNA polymerase (Gyorgy et al., 2015) 
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resources. For example, Darlington et al. recently developed a ribosome allocator in E. coli 
to enable dynamic partitioning of the limited ribosome pool between native and 
heterologous pathways (Darlington et al., 2018). The system was able to tune expression 
of an orthogonal ribosome-specific 16S rRNA gene to steer ribosome resources between 
native and engineered pathways depending on the demand. A similar strategy has also been 
used to build a RNA polymerase allocator to direct transcriptional resources using 
orthogonal sigma factors (Segall‐Shapiro et al., 2014). In addition, Venturelli et al. 
developed a global cellular resource allocator by controlling the overall decay rate of host 
mRNA to reduce competition between endogenous and heterologous pathways (Venturelli 
et al., 2017).  
 
Creating, engineering, and exploiting variation 
Under certain conditions, cell-to-cell variation can be desirable and may be a feature that 
can be exploited in engineering applications. Indeed, native pathways take advantage of 
diversification, suggesting the potential untapped benefits of this line of research. 
Examples where there are fitness advantages to heterogeneous populations include 
diversification to counter uncertain environments and division of labor among cells 
(Davidson and Surette, 2008).  
 
Microbes can use cell-to-cell variation to increase their fitness by hedging against 
environmental uncertainty (Donaldson-Matasci, Lachmann and Bergstrom, 2008). For 
example, during the glucose-cellobiose diauxic shift, Lactococcus lactis populations 
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diversify to have cells that can metabolize cellobiose (Cel+) and cells that cannot (Cel-). 
Although Cel- cells are not able to grow in the cellobiose environment, when introduced 
into a new environment with galactose they are able to divide much faster than Cel+ cells. 
Thus, the non-growing population (Cel-) plays a bet hedging role to jump-start growth on 
a potential future carbon source (Solopova et al., 2014). When there is uncertainty about 
the future, population diversity can serve as a potential mechanism for insuring against 
environmental perturbations. 
 
Another potential benefit of creating variation is through division of labor (Shong, Jimenez 
Diaz and Collins, 2012; Bacchus and Fussenegger, 2013; Johns et al., 2016). Division of 
labor allows separation of pathways either spatially or temporally, exploiting advantages 
of different species and reducing complexity and burden imposed on one cell (Tsoi et al., 
2018).   
 
Distributing production pathways within a synthetic consortium can allow for division of 
labor in the spatial regime. This approach has been employed for the biosynthesis of 
various compounds such as oxygenated taxanes, ferruginol, isobutanol, benzylisoquinoline 
alkaloids, and flavonoids (Minami et al., 2008; Minty et al., 2013; Zhou et al., 2015; Jones 
et al., 2016, 2017; Fang et al., 2018). For example, Zhou et al. engineered an inter-species 
microbial consortium of E. coli and Saccharomyces cerevisiae to exploit the advantages of 
each microbe. In this system, E. coli is used for rapid production of intermediates based on 
its fast growth rate, while S. cerevisiae catalyzes oxygenation reactions due to its complete 
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protein expression system. This approach yielded 33 mg/L of oxygenated taxanes and also 
resulted in the highest titer (18 mg/L) of ferruginol that had been reported in the literature 
(Bacchus and Fussenegger, 2013).  
 
Production pathways can also be divided temporally. For example, Xu et al. developed a 
method allowing cells to separate different pathways in the temporal regime (Xu et al., 
2014). To do this, they developed a genetic circuit in E. coli that responds to accumulation 
of the intermediate malonyl-CoA. After malonyl-CoA has accumulated, the upstream 
pathway that produces it is shut down, and the downstream pathway is turned on to convert 
malonyl-CoA to fatty acids. Once malonyl-CoA is depleted, the upstream pathway is 
turned on again. This genetic circuit implements sequential switching between upstream 
and downstream production pathways, therefore using a temporal division of labor, which 
resulted in a more than two-fold improvement in fatty acid titer. 
 
4.5 Conclusions 
Cell-to-cell variation in metabolic engineering applications can have distinct and even 
opposing impacts. Depending on the circumstances, the optimal engineering approach may 
be to diminish, accept, or create cell-to-cell variation. Strategies that diminish variation 
should be employed when diversity has a negative impact on production and in 
circumstances where it is straightforward to design noise reduction circuits. However, in 
many cases, the most practical choice may be to accept that variation exists and to design 
gene circuits that mitigate its detrimental impact. This can be achieved by employing 
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dynamic control strategies to fine-tune heterologous (or other) pathways corresponding to 
the variation. Finally, creating and exploiting variation can be beneficial for robust growth 
and improved production and can be achieved by dividing pathways spatially or temporally 
in order to exploit advantages of different genotypes or to reduce complexity and burden 
in one cell. Ultimately, it may be possible to combine subsets of these strategies for distinct 
parts of the metabolic engineering process, for example, exploiting temporal variation to 
avoid overloading cells while diminishing the impact of negative variation in well-
characterized genetic control elements.  
 
Advances in this area will benefit from new technologies for single-cell level quantification 
of variation in metabolic pathways. For instance, there are tools to quantify various 
intracellular compounds at the single-cell level, such as riboswitches or RNA that enable 
sensing of thiamine 5’-pyrophosphate (You, Litke and Jaffrey, 2015), 5-diphosphate and 
S-adenosylmethionine (Paige et al., 2012); expanding this toolkit will make quantification 
of variability more straightforward. These tools can join biosensors coupled with 
expression of reporters to read out single-cell levels of engineered products, for instance 
L-methionine and branched-chain amino acids (Mustafi et al., 2012, 2014). A potential 
downside of these methods is that they rely on indirect measurements or require 
identification of specific biosensors. An alternative is to use chemical imaging methods to 
more directly quantify pathway intermediates and end-products (Prince, Frontiera and 
Potma, 2017), and this represents an important future area for technological development. 
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In addition, microarray and microfluidic methods also show promise for quantifying 
variation in a high throughput manner (Ibáneza et al., 2013; Demling et al., 2018).  
 
Researchers are just beginning to appreciate and quantify cell-to-cell variation and to 
develop strategies for managing variation in metabolic engineering applications. We 
anticipate that the continued development of technologies that enable single-cell level 





Chapter 5: Transcriptional regulation of E. coli for metabolic engineering using 
transcription factor sponge 
5.1 Abstract 
Transcription factor decoy binding sites are short DNA sequences that can serve as 
“sponges” to titrate a transcription factor away from its natural binding sites, therefore 
regulating gene expression. In this research, we harnessed decoy sites to develop synthetic 
transcription factor sponge systems to regulate an E. coli metabolic pathway. We showed 
that transcription factor sponges can effectively regulate expression of genes located in 
either a plasmid or the genome. Tunability of the sponge can be engineered via changes in 
copy number or modifications to the DNA decoy site sequence. Using arginine 
biosynthesis as a showcase, we observed a 16-fold increase in arginine production when 
we introduced the sponge system to steer the metabolic pathway towards increased arginine 
biosynthesis. In contrast to brute force approaches like transcription factor knock-outs or 
knock-down strategies using CRISPRi, the arginine production strains developed with the 
sponge-based approach showed no growth differences compare to wild type strains. 
Sponge-based production strain also showed high genetic stability, where 50% of 
production strains with the knock-out acquired mutations in the production plasmid after 6 
rounds of cyclic culture, whereas no mutations were detected with the sponge-based 
production strains. Our study shows that transcription factor sponges can be a powerful 
tool for regulating metabolic pathways in E. coli with low fitness burden and high genetic 
stability. Moreover, sponge systems are tunable, easy to design, and compact, with only 




DNA sequences that contain transcription factor binding sites can competitively bind with 
transcription factors, serving as decoy sites. Decoy sites are abundant in natural genomic 
DNA of both eukaryotic and prokaryotic cells (Kemme et al., 2016). For example, the 
inducible transcription factor Egr-1 is suggested to have ~106-107 natural decoy binding 
sites on the genome (Esadze et al., 2014; Kemme, Esadze and Iwahara, 2015; Kemme et 
al., 2016). These decoy sites effectively titrate transcription factors away from their 
functional promoters, therefore altering cellular physiology. Another well-studied example 
are the decoy sites for the transcription factor CCAAT/enhancer-binding protein α 
(C/EBPα), where sites exist in tandem repeats that can effectively sequester free C/EBPα 
and reduce transcriptional output from promoters it controls (Tang and Lane, 1999; Liu et 
al., 2007). In addition, natural decoy sites have also been found to alter gene expression 
response dynamics (Lee and Maheshri, 2012), extend the half-life of transcription factors 
(Burger, Walczak and Wolynes, 2010) and to allow cross-talk between transcription factors 
(Liu et al., 2007). 
 
Since decoy binding sites are easy to design, do not compete transcriptional and 
translational resources and occupy negligible space because it is a short DNA sequence, 
synthetic decoy sites have also been designed to regulate certain transcription factors and 
alter gene expression dynamics for synthetic genetic circuit construction (Lee and 
Maheshri, 2012; Potvin-Trottier et al., 2016). For example, Potvin-Trottier et al. employed 
decoy binding sites to improve robustness of an oscillator. Decoy sites were designed to 
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act as a “sponge” to soak up small numbers of the transcription factor TetR, increasing the 
threshold of a TetR-controlled promoter, therefore significantly reducing noise and 
improved regularity of the oscillator (Potvin-Trottier et al., 2016). Moreover, synthetic 
decoy sites have been applied for therapeutic purposes, for example, targeting the 
transcription factor E2F in order to inhibit intimal hyperplasia after vascular injury 
(Morishita et al., 1995), STAT3 for cancer therapy (Leong et al., 2003) and NK-κB to 
prevent myocardial infarction (Morishita et al., 1997). 
 
In metabolic engineering, inhibiting the effects of transcription factors can redirect 
metabolic flux to enhance production. Amino acid biosynthesis is well-studied example 
since several amino acid biosynthetic pathways are tightly regulated by transcriptional 
repressors to prevent overproduction (Becker and Wittmann, 2012). To increase amino 
acid biosynthesis, these transcription factors can be deleted from the genome to remove 
transcriptional repression of the production pathway. However, transcription factor 
deletion is frequently associated with reduced fitness due to their broader regulatory role. 
For example, when the transcription repressor argR is deleted in an arginine production 
strain of E. coli growth-rate is only 35% that of wide-type values due to limitations 
associated with pyrimidine nucleotide biosynthesis (Sander et al., 2019). Significant 
reductions in fitness make these strains prone to genetic drift and can reduce production in 
scaled-up bioprocesses. One way to ameliorate the fitness deficit is to knock-down instead 
of knock-out the transcription factor, such as through the use of CRISPRi. For example, 
Sander et al. reported a CRISPRi knock-down of arginine production in an E. coli strain 
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that has a 2-fold increase in growth rate compared with its genomic knock-out counterpart. 
Importantly, arginine production was maintained in the knock-down strain (Sander et al., 
2019). This study suggests that down-regulating transcription factors can be an alternative 
strategy to full knock outs when designing production strains.  
 
However, toxicity has been reported associated with CRISPRi knock-down systems (Rock 
et al., 2017; Cho et al., 2018), which may potentially affect production and cellular fitness. 
Moreover, engineered strains employed in metabolic engineering commonly need to carry 
large clusters of heterologous genes. The fact that CRISPRi systems frequently require two 
plasmids can impose a practical limit on compatibility.  
 
In contrast, titrating transcription factors using decoy binding sites does not require 
transcriptional or translational resources, and decoy binding sites are short (~20bp) DNA 
sequences and therefore do not necessarily require additional plasmids. We hypothesized 
that decoy binding sites could serve as a strategy to regulate metabolic pathways by 
relieving transcription factor regulation for constructing robust production strains.  
 
In the current research, we sought to harness decoy binding sites to develop a synthetic 
sponge system to soak up free transcription factors to alter metabolic pathway expression. 
We show that the synthetic sponge system can effectively alter transcriptional outputs of 
downstream promoters of targeted transcription factors. Importantly, this sponge effect is 
tunable, which we show by changing plasmid copy number and also the sequence of decoy 
	
	 82	
sites. To show the effectiveness of using a transcription factor sponge in metabolic 
engineering, we use arginine biosynthesis as a showcase. We designed synthetic sponge 
systems for the arginine production pathway transcription repressor ArgR. Our results 
show that ArgR repression is effectively inhibited by the introduction of a synthetic sponge. 
Compared with CRISPRi knock-down designs, the sponge system results in stronger 
inhibition of ArgR without a corresponding reduction in growth rate. Using liquid 
chromatography–mass spectrometry (LC-MS) to determine arginine production, we 
demonstrate that production is increased 16.7-fold compared to the parental production 
strain lacking control of ArgR inhibition. The synthetic sponge targeting argR shows no 
detectable growth difference, while the genomic knock-out strain exhibits a 50% growth-
rate reduction and the CRISPRi knock-down production strains exhibits a 30% reduction 
in growth rate compared to wild type. Further, after a cyclic culturing process to test the 
potential for genetic drift in a scaled-up process, we found that all genomic knock-out 
cultures obtained mutations, while no mutation were detected in the production strain based 
on synthetic sponge system over the same period. This work suggests the transcriptional 
sponge system is a novel tool for regulating metabolic pathways for biosynthesis. 
Advantages include its simplicity and small size, fitness, and genetic stability, which 
suggest its broad potential in metabolic engineering applications. 
 
5.3 Results 
Altering gene expression with the sponge system 
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To investigate the general effects of the transcription factor sponge, we first employed two 
widely used inducible promoters, Plac and Ptet controlled by the transcription factors LacI 
and TetR, respectively. To construct a sponge system for each, we inserted a LacI or TetR 
binding site sequence acquired from the Plac or Ptet promoter region into a plasmid. To avoid 
unexpected transcription results from the insertion of the decoy transcription binding sites, 
a terminator was placed immediately after sponge sequence. (Fig. 1a). 
 
First, to test the effects of the LacI sponge, we co-transformed the sponge system with a 
reporter plasmid that consist of Plac driving expression of red fluorescent protein (rfp) (Fig. 
1a). With no sponge present, RFP levels are low without induction and increase 
dramatically with 1mM IPTG induction, as IPTG inhibits LacI from binding to the 
promoter. These 0 and 1mM IPTG induction cases serve as negative and positive controls 
for our sponge experiments. If the sponge is working, introducing it should increase RFP 
expression as LacI is titrated away so it can no longer repress the Plac promoter. As 
expected, we found that the LacI sponge allows significantly elevated transcription activity, 
which is a function of the copy number of the sponge plasmid. To do this, we introduced 
the LacI sponge into plasmids with different replication origins, p15A, ColE1, and pMR1*, 
representing low (~10), medium (~20), high (~500) copy numbers plasmids. Using the Plac-
rfp reporter, we observed a clear trend of increased transcriptional activity as the copy 
number of the sponge plasmid is increased (Fig. 1b). This suggests that the sponge effect 
can be tuned by controlling the copy number of the sponge. For the LacI sponge in a 
plasmid with a pMB1* origin, the Plac expression level is comparable with the positive 
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control, the reporter plasmid without the sponge but induced with a saturating level of IPTG 
(1mM) (Fig. 1b).  
 
We conducted a similar set of experiments using the transcription factor TetR and promoter 
Ptet. Similarly, Ptet expression with the sponge is comparable to conditions with 
intermediate induction with aTc (12nM). The elevated basal expression by the sponge 
suggests it can effectively reduce free transcription factor, and alter transcription activity 




Figure. 5-1 Sponge system for the transcriptional repressors LacI and TetR. (a) Schematic view 
of the sponge plasmid design for LacI and TetR. The LacI or TetR sponge sequence is inserted 
into a plasmid, where the sequence is immediately followed by transcription terminator. The copy 
number of this plasmid depends on the experiment, but pMB1* is shown as an example. The 
reporter plasmid contains the Plac or Ptet promoter driving expression of red fluorescent protein 
(rfp) on a low-copy SC101 origin plasmid. (b) Regulatory effects of the LacI sponge system in 
p15A, ColE1 or pMB1* origin and TetR sponge system in pMB1 origin. Error bars show 




Controlling a native metabolic pathway using the synthetic sponge system  
We next sought to test whether the sponge effect could be used to control the activity of a 
native metabolic pathway, as this is relevant to metabolic engineering. To do this, we 
focused on arginine biosynthesis as a model system. The arginine production pathway is 
regulated by the transcription factor ArgR, which controls 31 targets and functions as a 
strong repressor of the arginine pathway when arginine is produced, preventing its 
overproduction (Fig. 2a). To establish a baseline for the minimum and maximum levels of 
activity we conducted tests with and without arginine. To test the effect of transcriptional 
repression by ArgR, we employed a set of six transcriptional reporters for the arginine 
production pathway that consist of a subset of native promoters driving expression of green 
fluorescent protein (gfp): PargA-gfp, PargCBH-gfp, PargD-gfp, PargE-gfp, PargF-gfp, and PargI-gfp. 
We measured the transcription activity of all six reporters upon supplementation with 
0.06mM, 0.66mM or 6.6mM arginine. In the presence of arginine, ArgR can complex with 
arginine and repress transcription of genes in the arginine production pathway. Note that 
this behavior is inverted from the LacI and TetR cases, where inducer inhibits repression, 
causing elevated fluorescence. As expected, increasing concentrations of arginine have a 
clear negative impact on the transcriptional activity of all reporters (Fig. 2b).  
 
We next constructed a sponge system for ArgR to test whether it could restore 
transcriptional activity of the production pathway in the presence of arginine. To test this, 
we designed an ArgR sponge system which consist of a 21bp artificial consensus region. 
To determine the consensus, we calculated the strict consensus region of all 31 known 
	
	 86	
ArgR binding sites based on its position weight matrix. We co-transformed the sponge 
system with each of the arginine pathway reporters, and further measured the 
transcriptional activity in the presence of 0.66mM arginine. We chose 0.66mM arginine 
because it is a production-relevant concentration and most arginine pathway genes reach a 
repression plateau above this concentration (Fig. 2b). In a strain containing the ArgR 
sponge with arginine present, we observed a significant restoration of transcriptional 
activity, suggesting the sponge system can effectively titrate ArgR away from its genomic 
targets and up-regulate the arginine production pathway (Fig. 2c). However, other designs 
using ArgR binding sites from the native ArgR promoter region as a sponge show little 















































Figure. 5-2 Development of ArgR sponge for regulating native arginine biosynthesis pathway. 
(a) Schematic view of native arginine production pathway in E. coli and design of the ArgR 
sponge system. (b) Inhibition of the arginine production pathway genes by different 
concentrations of arginine. Reporter expressions with 0mM are normalized to 1. (c) Up-regulation 
of arginine production pathway genes by introduction of the ArgR sponge system in ColE1 
origin. (d) Regulatory effects of different sequences in the ArgR sponge library. Library members 
are sorted from high (most effective as a sponge) to low (least effective).  
 
Tunable regulation of the transcription factor sponge  
To evaluate whether the sponge effect could be tuned by modifying the sequence of the 
ArgR binding site, we constructed a library of ArgR sponge sites and tested the sponging 
effect using PargA-GFP reporter We found that although all members in the ArgR sponge 
library shared the same position weight matrix logo, sequence differences in the non-
conservative region of the ArgR binding sites resulted in variants with a range of impacts, 
from no effect to full restoration of transcription activity, suggesting that the sponge effect 
is highly dependent on the DNA sequence and is tunable if the binding sequence is 




Because the sponge effect is a function of copy number of the sponge (Fig. 1b), we 
reasoned that an alternative way of engineering tunability would be to varying he copy 
number. To achieve this, we employed a plasmid system with an IPTG-inducible phage P1 
replication system for tunable copy number (Fig. 3a). Using a fluorescent reporter driven 
by a constitutive promoter to initially report the copy number inducibility, we confirmed 
an increase in fluorescence level upon induction by IPTG (Fig. 3b). Next, we incorporated 
the ArgR consensus sponge into the inducible copy number plasmid, and measured 
transcriptional activity of an arginine pathway reporter (PargA-gfp) in the presence of 
arginine. As expected, we observed a trend of increased expression of the arginine pathway 
reporter with increased IPTG induction, suggesting that the sponge effect can be controlled 






Figure. 5-3 Inducible copy number ArgR sponge system. (a) Schematic view of the design of the 
inducible ArgR sponge system. (b) Plasmid copy number increased as IPTG concentration 
increased. (c) ArgR sponge effects enhanced as IPTG induces higher copy number of the plasmid. 
Error bars show standard errors from 3 biological replicates. 
 
Enhanced arginine yields without growth deficit using the synthetic sponge system 
To confirm the sponge effect and quantify its ultimate impact on arginine production, we 
introduced the ArgR sponge into an arginine production strain. This strain, which we 
denote ArgA*, harbors a plasmid expressing a mutated version of argA, argA (H15Y), 
where allosteric feedback is removed. To quantify arginine production, we employed LC-
MS to measure the yields of arginine in the strains with and without the sponge after 24 
hours of fermentation. As we observed a significant up-regulation of arginine production 
pathway genes with our ArgR sponge system (Fig. 2), we reasoned that arginine production 
should also increase with the ArgR sponge. Indeed, we observed a 16.7-fold increase in 
arginine yields after co-transforming ArgA* for the strain transformed with the ArgR 
sponge system compared to the same strain without the sponge (Fig. 4a). These results 
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confirm that the sponge system can effectively steer the metabolic pathway activity, 
increasing yields. Importantly, even with the increase in arginine production, we observed 
no detectable growth differences comparing with the wide type strain (Fig. 4b). This result 
is in contrast to strategies based on knock-out or CRISPRi knock-down, which have been 
reported to have a significant growth deficit. These results suggest that the sponge system 
is an effective strategy for redirecting metabolic flux that imposes a low burden to the cell. 
  
 
Figure. 5-4 Yields and growth curves of arginine production strains. (a) Arginine yields of 
production strains measured by LC-MS. (b) Growth curves of different arginine production 
strains. Error bars show standard deviation from 3 biological replicates. 
 
5.4 Conclusions 
Knock-out or knock-downs of transcription factors are common strategies to redirect 
metabolic flux in biosynthesis. However, because transcription factor can have global 
impacts on cell physiology, knock-out strategies are frequently associated with broad 
physiological consequences (He, Murabito and Westerhoff, 2016), such as reduced 
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bacterial fitness. In contrast, knock-down strategies, such as those based on CRISPRi can 
largely reduce fitness cost, yet maintain productivity. However, the toxicity effect and the 
large size of the CRISPRi system limits its application in metabolic engineering (Rock et 
al., 2017; Cho et al., 2018). 
 
In this research, we harnessed decoy binding sites to develop a synthetic sponge system to 
titrate transcription factors, in order to regulate expression of genes in a metabolic pathway 
without reducing fitness, therefore increasing yield and genetic stability in a metabolic 
engineering context. We showed that the transcription factor sponge system is an effective 
tool for altering gene expression for targets both in a plasmid and on the genome. 
Importantly, the effect of the sponge can be tuned by changing its copy number or DNA 
sequence. As an application, we used the sponge system to control arginine biosynthesis 
and showed that it can regulate metabolic flux by increasing transcriptional activity of the 
arginine production pathway, resulting in a more than 16-fold increase in arginine 
production compared with its parental strain lacking the sponge. Importantly, in contrast 
to production strains that are based on either knock-out or CRISPRi knock-down 
approaches, the production strain based on the sponge system exhibits no detectable growth 
difference compared to wild type. This suggests that using the sponge to selectively titrate 
away transcription factors may have a much smaller burden compared to knock-out or 
knock-down alternatives. Since fitness deficits can compromise genetic stability during the 
scale-up process, we also tested the genetic stability of the alternative designs. We found 
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that the production strain based on the sponge system has higher genetic stability than the 
knock-out system.  
 
We have shown that the sponge approach is a powerful system for selectively blocking the 
effects of a transcription factor and regulating metabolic pathways in bacteria. When 
applied to arginine production, the sponge approach increased yield without a detectable 
growth deficit and exhibited high genetic stability. Our research suggests that using the 
sponge system in metabolic engineering may allow us to develop strains that are productive 
and with higher genetic stability. 
 
5.5 Materials and Methods 
Strains 
We used E. coli BW25113 as the wild type strain. ΔargR was derived from E. coli 
BW25113 by deleting argR gene using homologous recombination. We used the forward 
primer 5’- AAG CAA GAA GAA CTA GTT AAA GCA TTT AAA GCA TTA CTT AAA 
GAA GAG AAg tgt agg ctg gag ctg ctt c-3’ and the reverse primer 5’- CCT GGT CGA 
ACA GCT CTA AAA TCG CTT CGT ACA GGT CTT TGA CTG TGA AAa ttc cgg gga 
tcc gtc gac c-3’. Capitalized letters indicate the homologous recombination extension.  
 
The ArgA* production strain was created by transforming BW25113 with an ArgA* 
production plasmid containing PargA-ArgA* (H15Y). To construct the ArgA* production 
plasmid, we amplified the promoter and gene region of argA, PargA-ArgA, from E. coli 
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BW25113 using the forward primer 5’- GCCTCTCCCGAGCAAAAG -3’ and reverse 
primer 5’- TTACCCTAAATCCGCCATCAAC -3’. We then introduced mutations in the 
PCR product of PargA-ArgA to create PargA-ArgA (H15Y) using the forward primer 5’- 
GGG ATT CCG CTA TTC AGT TCC -3’, and reverse primer 5’- TTA CCC TAA ATC 
CGC  CAT CAA C -3’. PargA-ArgA (H15Y) was then cloned on the low-copy (SC101) 
plasmid pBbS5C. 
 
Transcription factor sponge plasmids 
LacI sponge plasmid 
We cloned the LacI binding site sequence AATTGTGAGCGGATAACAATT into the 
p15A replication origin plasmid pBbA5A, or ColE1 replication origin plasmid pBbE5A, 
using the forward primer 5’- AAT TGT GAG CGG ATA ACA ATT cca tcg ttg aac agt 
acg aac -3’, and reverse primer 5’- AAT TGT TAT CCG CTC ACA ATT cca tca aac agg 
att ttc gcc -3’. For cloning into pMB1 (high copy derivative) plasmid pUC19, we used the 
forward primer 5’- AAT TGT GAG CGG ATA ACA ATT taa tgc agc tgg cac gac -3’, and 
reverse primer 5’- AAT TGT TAT CCG CTC ACA ATT ggt ttg cgt att ggg cgc -3’. 
Capitalized letters indicate the homologous region. 
 
TetR sponge plasmid 
We used the forward primer 5’- TCC CTA TCA GTG ATA GAG Ata atg cag ctg gca cga 
c -3’, and reverse primer 5’- TCT CTA TCA CTG ATA GGG Agg ttt gcg tat tgg gcg c -3’ 
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to clone the TetR binding site sequence TCCCTATCAGTGATAGAGA into pMB1 (high 
copy derivative) plasmid pUC19. 
 
ArgR sponge plasmid 
For the ArgR consensus sponge plasmid, we introduced the consensus ArgR binding site 
sequence TTA TTT GCA TAA AAA TTC ATT TGT ATG CAC A into the ColE1 
replication origin plasmid pBbE5A using the forward primer 5’- TTA TTT GCA TAA 
AAA TTC ATT TGT ATG CAC Agc tga agg tcg tca ctc ca -3’, and reverse primer 5’- 
AAT GAA TTT TTA TGC AAA TAA CAG TCA GCC CCc cac cgt ctt tca gtt tca ga -3’. 
 
Bacterial growth conditions 
For all experiments, bacteria were cultured in M9 minimal medium with 5 g/L glucose at 
37C with 200 rpm shaking. Overnight cultures inoculated from a single colony were diluted 
1:50 in M9 minimal medium with 5g/L glucose and antibiotics, where appropriate. The 
diluted cultures were then precultured for 2h, arginine was added when required, we then 
continued culturing at 37 C with 200 rpm shaking. Optical density (OD) 660nm readings, 
GFP readings (excitation 480, emission 510) and RFP readings (excitation 580, emission 
610) were taken using a BioTek Synergy H1m plate reader (BioTek, Winooski, VT) every 
15 minutes. 
 
Arginine production experiments 
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Overnight cultures of production strains were diluted 1:50 in 5 ml M9 minimal medium 
with 5 g/L glucose with antibiotics when appropriate. Diluted cultures were then cultured 
for 24 h at 37C with 200 rpm shaking. Bacterial cultures were then placed on ice and lysed 
with 10 cycles of sonication (10 seconds ON, 30 seconds OFF, 20% amplitude). 40 µl of 
cell lysate was mixed with acetone at a 1:8 ratio, vortexed and kept on ice for 30 minutes. 
Samples were then centrifuged at 15,000 rcf for 10 minutes at 10C to pellet proteins and 
lipids. Supernatant was transferred to a new tube, leaving behind the protein pellet. The 
sample was the dried in a speed vacuum centrifuge and then reconstituted by adding 40µl 
µL H20 with 0.1% formic acid and vortexed.  Samples were placed on ice for 15 minutes 
and centrifuged to remove any protein or lipid that was not removed.  Supernatant was then 





Chapter 6: Conclusion 
In this thesis, we investigated the fitness cost of E. coli in the context of antibiotic resistance 
and metabolic engineering. For the sections related to antibiotic resistance, we focused on 
MarA and its natural inducer salicylate as our model system. As MarA and its downstream 
genes are known to impose significant burden to the cell, we investigated the fitness cost 
origin of MarA and how salicylate can amplify the fitness cost related to MarA (Chapter 
2). Next, we focused on another antibiotic resistant mechanism that can also reduce fitness 
of bacteria, persister formation. We found that salicylate can significantly reduce bacterial 
metabolic activity, dissipate proton motive force and induce persister (Chapter 3). Through 
our research on fitness cost related to antibiotic resistance, our results show that we may 
be able to exploit natural chemicals, such as salicylate, to increase the fitness cost of 
resistance machinery in order to reduce the proportion of resistant cells within a population. 
 
Since fitness cost is a key factor that affects the productivity and scale up process in 
biotechnology industry, we next explored fitness cost and methods to ameliorate it in the 
context of metabolic engineering. We first reviewed the origins of fitness cost and cell-to-
cell variation in metabolic engineering, then summarized existed technologies that allows 
us to ameliorate cost and reduce variation (Chapter 4). Next, we developed a low fitness 
cost tool to regulate native metabolic pathway for biosynthesis. We showed that this 
synthetic tool, which uses decoy binding sites, can effectively steer flux by sponging free 
transcription factor, significantly increasing yield without introducing growth deficit. 
Another direct advantage of the reduced fitness cost is that the sponge approach allows for 
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much high genetic stability compared with the production strain that has the transcription 
factor knocked out (Chapter 5). 
 
In summary, this thesis provided a further understanding into the origin of bacterial fitness 
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